Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
MannKind Corporation (MNKD)
USD3.99
+0.11 (+2.84%)
US NASDAQ Healthcare Biotechnology
Address
30930 Russell Ranch Road 91362
Danbury, CA, US
Danbury, CA, US
CEO
Michael E. Castagna
Website
mannkindcorp.com
IPO
2004-07-28
CIK 899460 ISIN US56400P7069
Description
MannKind Corporation operates as a biopharmaceutical firm, primarily focused on innovating and bringing to market respiratory-delivered treatments. Its efforts are directed towards tackling endocrine system disorders and rare lung conditions within the U.S. market. The company's key product is Afrezza, an inhaled insulin designed to improve glycemic control for adults managing diabetes. MannKind also actively markets Thyquidity, promoting it to adult and pediatric endocrinologists and other healthcare professionals for the treatment of hypothyroidism. In terms of collaborations, MannKind holds a strategic licensing and partnership agreement with United Therapeutics Corporation. Furthermore, it is collaborating with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), which is a synthetic variant of human vasoactive intestinal peptide intended to shield cells from inflammatory processes. Established in 1991, MannKind Corporation's corporate offices are located in Westlake Village, California.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD3.99
+0.11 (+2.84%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
6M
Beta
1.11
Float Shares
302.44M
Free Float %
97.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.38% | -7.87% | +24.24% | -42.05% | -35.31% | -42.15% | -30.51% | -27.59% | -18.61% | -29.87% | -95.34% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (19 ratings, all time)
Buy
Price Targets & DCF
Current price
3.99
Low
6.00
+50.4%
Consensus
8.25
+106.8%
Median
8.50
+113.0%
High
10.00
+150.6%
Ratings Trend (MoM)
88% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 7 | -1 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 2 |
7.00
+75.4%
|
| Last Quarter | 2 |
7.00
+75.4%
|
| Last Year | 6 |
8.50
+113.0%
|
| All Time | 8 |
9.13
+128.8%
|
Quality scores
Altman Z-Score
-4.51
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
4 / 10
Developing
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+22.2% ★ Q1'26: +15.1% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-79.4% Q1'26: -231.5% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-20.9% Q1'26: -8.3% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%+4.4% ★ Q1'26: -3.3% (vs Q1'25)
-
ROIC Biotechnology: -16.1%+6.1% ★ Q1'26: -4.9% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+10.7% Q1'26: -3.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×17.20× Q1'26: 32.14× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2006 actual |
Dec 2008 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 5 EPS Ana. |
Dec 2027 6 Rev. Ana. 5 EPS Ana. |
Dec 2028 8 Rev. Ana. 8 EPS Ana. |
Dec 2029 7 Rev. Ana. 6 EPS Ana. |
Dec 2030 7 Rev. Ana. 6 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
100.0K
est: 84.6K (+18.2%)
|
20.0K
est: 22.2K (-10.0%)
|
93.0K
est: 108.6K (-14.4%)
|
50.0K
est: 84.7K (-41.0%)
|
35.0K
est: 37.1K (-5.6%)
|
174.76M
est: 168.18M (+3.9%)
|
11.75M
est: 9.73M (+20.7%)
|
27.86M
est: 35.36M (-21.2%)
|
63.04M
est: 62.07M (+1.6%)
|
65.14M
est: 62.88M (+3.6%)
|
75.44M
est: 80.01M (-5.7%)
|
99.77M
est: 99.59M (+0.2%)
|
198.96M
est: 248.37M (-19.9%)
|
285.50M
est: 281.03M (+1.6%)
|
348.97M
est: 342.39M (+1.9%)
|
459.90M
445.10M – 466.03M
+34.3% YoY
|
518.31M
499.73M – 536.08M
+12.7% YoY
|
532.66M
532.47M – 532.85M
+2.8% YoY
|
605.57M
567.34M – 629.68M
+13.7% YoY
|
698.45M
654.35M – 726.26M
+15.3% YoY
|
| EBITDA |
-225.18M
est: -197.43M (-14.1%)
|
-288.41M
est: -283.49M (-1.7%)
|
-135.86M
est: -146.04M (+7.0%)
|
-123.68M
est: -113.07M (-9.4%)
|
-133.74M
est: -126.15M (-6.0%)
|
146.54M
est: -57.61M (+354.4%)
|
-102.21M
est: -71.66M (-42.6%)
|
-75.60M
est: -89.71M (+15.7%)
|
-38.84M
est: -43.26M (+10.2%)
|
-44.66M
est: -36.28M (-23.1%)
|
-61.11M
est: -38.25M (-59.7%)
|
-56.32M
est: -54.68M (-3.0%)
|
15.13M
est: -47.10M (+132.1%)
|
77.47M
est: -53.29M (+245.4%)
|
27.52M
est: -64.93M (+142.4%)
|
-87.22M
-88.38M – -84.41M
-34.3% YoY
|
-98.29M
-101.66M – -94.77M
-12.7% YoY
|
-101.01M
-101.05M – -100.98M
-2.8% YoY
|
-114.84M
-119.41M – -107.59M
-13.7% YoY
|
-132.46M
-137.73M – -124.09M
-15.3% YoY
|
| EBIT |
-233.70M
est: -206.05M (-13.4%)
|
-300.70M
est: -298.04M (-0.9%)
|
-153.18M
est: -163.38M (+6.2%)
|
-138.98M
est: -128.95M (-7.8%)
|
-148.14M
est: -136.54M (-8.5%)
|
144.14M
est: -64.72M (+322.7%)
|
-104.01M
est: -73.77M (-41.0%)
|
-77.30M
est: -88.85M (+13.0%)
|
-41.00M
est: -50.59M (+19.0%)
|
-47.99M
est: -39.60M (-21.2%)
|
-64.35M
est: -31.56M (-103.9%)
|
-62.63M
est: -51.45M (-21.7%)
|
10.59M
est: -56.82M (+118.6%)
|
68.50M
est: -64.29M (+206.5%)
|
15.24M
est: -78.33M (+119.5%)
|
-105.21M
-106.62M – -101.83M
-34.3% YoY
|
-118.58M
-122.64M – -114.33M
-12.7% YoY
|
-121.86M
-121.90M – -121.82M
-2.8% YoY
|
-138.54M
-144.06M – -129.79M
-13.7% YoY
|
-159.79M
-166.15M – -149.70M
-15.3% YoY
|
| Net Income |
-230.55M
est: -203.43M (-13.3%)
|
-303.04M
est: -294.58M (-2.9%)
|
-170.56M
est: -183.23M (+6.9%)
|
-160.80M
est: -148.06M (-8.6%)
|
-169.37M
est: -152.56M (-11.0%)
|
125.66M
est: 163.21M (-23.0%)
|
-117.33M
est: -80.59M (-45.6%)
|
-86.98M
est: -101.75M (+14.5%)
|
-51.90M
est: -58.77M (+11.7%)
|
-57.24M
est: -48.46M (-18.1%)
|
-80.93M
est: -54.87M (-47.5%)
|
-87.40M
est: -47.44M (-84.2%)
|
-11.94M
est: 13.43M (-188.9%)
|
27.59M
est: 32.80M (-15.9%)
|
5.86M
est: 53.00M (-88.9%)
|
-14.25M
-29.84M – 12.56M
-126.9% YoY
|
55.14M
-140.72M – 193.49M
+486.9% YoY
|
68.73M
-76.64M – 121.35M
+24.7% YoY
|
96.03M
88.15M – 101.00M
+39.7% YoY
|
143.97M
132.15M – 151.42M
+49.9% YoY
|
| SGA |
42.00M
est: 61.8K (+67,841.9%)
|
55.34M
est: 16.2K (+340,556.2%)
|
40.31M
est: 79.4K (+50,674.6%)
|
40.63M
est: 61.9K (+65,540.2%)
|
45.47M
est: 27.1K (+167,659.9%)
|
46.93M
est: 122.90M (-61.8%)
|
74.96M
est: 7.11M (+954.2%)
|
79.72M
est: 25.84M (+208.5%)
|
74.67M
est: 45.36M (+64.6%)
|
59.04M
est: 56.12M (+5.2%)
|
77.42M
est: 59.48M (+30.2%)
|
91.47M
est: 71.05M (+28.8%)
|
94.31M
est: 157.00M (-39.9%)
|
94.33M
est: 177.64M (-46.9%)
|
144.14M
est: 216.42M (-33.4%)
|
290.70M
281.34M – 294.58M
+34.3% YoY
|
327.62M
315.88M – 338.85M
+12.7% YoY
|
336.69M
336.57M – 336.81M
+2.8% YoY
|
382.78M
358.61M – 398.02M
+13.7% YoY
|
441.49M
413.61M – 459.07M
+15.3% YoY
|
| EPS |
-22.62
est: -17.88 (-26.5%)
|
-14.92
est: -14.84 (-0.5%)
|
-7.50
est: -8.80 (+14.8%)
|
-6.60
est: -5.76 (-14.6%)
|
-4.68
est: -4.15 (-12.8%)
|
1.37
est: 0.58 (+138.3%)
|
-1.13
est: -1.13 (+0.0%)
|
-0.60
est: -0.58 (-2.9%)
|
-0.31
est: -0.26 (-17.4%)
|
-0.26
est: -0.18 (-44.7%)
|
-0.37
est: -0.27 (-37.6%)
|
-0.44
est: -0.32 (-36.8%)
|
-0.04
est: 0.04 (-203.0%)
|
0.10
est: 0.11 (-5.4%)
|
0.02
est: 0.17 (-88.3%)
|
-0.02
-0.10 – 0.04
-111.7% YoY
|
0.14
-0.45 – 0.62
+800.0% YoY
|
0.15
-0.24 – 0.39
+8.9% YoY
|
0.31
0.28 – 0.32
+100.5% YoY
|
0.46
0.42 – 0.48
+49.9% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-28 | Wells Fargo | Overweight | Overweight | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 4/5 | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 4/5 | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
34.47M
OE per share TTM
0.11
Owner's Yield
3.14%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
34.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
60
Total invested
31.29M
Insider transactions (90d)
1
Beneficial owners (>5%)
21
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (1) BlackRock, Inc. | 20.99M | 8.40% | 20.29M | — | 20.99M | — | HC | Delaware | 2022-02-01 | ↗ |
| 2 | STATE STREET CORPORATION | 13.05M | 5.19% | — | 12.68M | — | 13.05M | HC | — | 2022-02-10 | ↗ |
| 3 | The Vanguard Group - 23-1945930 | 12.65M | 5.03% | — | 234.0K | 12.23M | 413.6K | IA | Pennsylvania For | 2022-02-10 | ↗ |
| 4 | CVI Investments, Inc. | 10.65M | 4.90% | — | 10.65M | — | 10.65M | CO | Cayman Islands | 2020-02-10 | ↗ |
| 5 | Heights Capital Management, Inc. | 10.65M | 4.90% | — | 10.65M | — | 10.65M | CO | Delaware | 2020-02-10 | ↗ |
| 6 | Design International II, L.P. | 10.46M | 7.18% | — | 10.46M | — | — | PN | Delaware | 2018-07-17 | ↗ |
| 7 | Design Fund II, L.P. | 9.86M | 6.77% | — | 9.86M | — | — | PN | Delaware | 2018-07-17 | ↗ |
| 8 | Edward C. Johnson 3d | 8.90M | 7.87% | — | — | 8.90M | — | IN | United States of America | 2010-02-16 | ↗ |
| 9 | FMR LLC | 8.90M | 7.87% | — | — | 8.90M | — | HC | Delaware | 2010-02-16 | ↗ |
| 10 | KEVIN C. TANG | 8.70M | 4.99% | — | 8.70M | — | — | IN | UNITED STATES | 2012-02-13 | ↗ |
| 11 | TANG CAPITAL MANAGEMENT, LLC | 8.70M | 4.99% | — | 8.70M | — | — | OO | DELAWARE | 2012-02-13 | ↗ |
| 12 | TANG CAPITAL PARTNERS, LP | 8.70M | 4.99% | — | 8.70M | — | — | PN | DELAWARE | 2012-02-13 | ↗ |
| 13 | 52-2203385 | 6.84M | 9.32% | — | 6.84M | — | 6.84M | IV, CO | Maryland | 2007-04-10 | ↗ |
| 14 | Deerfield Management Company, L.P. | 5.22M | 5.17% | — | 5.22M | — | — | PN | Delaware | 2017-04-19 | ↗ |
| 15 | Sabby Healthcare Master Fund, Ltd. | 4.05M | 2.89% | — | 3.75M | — | 3.75M | CO | Cayman Islands | 2018-04-09 | ↗ |
| 16 | Company, L.P. | 2.44M | 1.30% | — | 2.44M | — | — | PN | Delaware | 2019-02-12 | ↗ |
| 17 | James E. Flynn | 2.44M | 1.30% | — | 2.44M | — | — | IN | United States | 2019-02-12 | ↗ |
| 18 | L.P. | 2.44M | 1.30% | — | 2.44M | — | — | PN | Delaware | 2019-02-12 | ↗ |
| 19 | Deerfield Mgmt, L.P. | 2.28M | 1.91% | — | 2.28M | — | — | PN | United States | 2018-07-17 | ↗ |
| 20 | Deerfield Private Design International II, L.P. | 1.30M | 0.70% | — | 1.30M | — | — | PN | British Virgin Islands | 2019-02-12 | ↗ |
| 21 | Deerfield Private Design Fund II, L.P. | 1.14M | 0.61% | — | 1.14M | — | — | PN | Delaware | 2019-02-12 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
60
-201 vs prev Q
New positions
9
Closed positions
204
Increased
24
Reduced
18
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BLACKROCK, INC. | 28.95M +239.4K (+0.8%) | 164.14M +10.0M (+6.5%) | 9.44% +0.021 pp | 0.00% +0.000 pp | USD5.86 -3.2% | 6 qtrs — |
| 2 | VANGUARD GROUP INC | 17.88M +250.3K (+1.4%) | 101.38M +6.7M (+7.1%) | 5.83% +0.047 pp | 0.00% +0.000 pp | USD2.85 +98.9% | 36 qtrs — |
| 3 | STATE STREET CORP | 14.62M +3.9M (+36.2%) | 82.91M +25.2M (+43.8%) | 4.77% +1.244 pp | 0.00% +0.001 pp | USD4.00 +41.8% | 36 qtrs — |
| 4 | RUBRIC CAPITAL MANAGEMENT LP | 7.48M -3.9M (-34.5%) | 42.39M -18.9M (-30.8%) | 2.44% -1.306 pp | 0.51% -0.185 pp | USD5.37 +5.6% | 2 qtrs — |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 7.37M -11.4K (-0.2%) | 41.82M +2.2M (+5.4%) | 2.40% -0.018 pp | 0.00% +0.000 pp | USD3.20 +77.2% | 36 qtrs — |
| 6 | NITORUM CAPITAL, L.P. | 5.33M -1.2M (-18.8%) | 30.20M -5.0M (-14.3%) | 1.74% -0.416 pp | 6.68% +0.486 pp | USD4.09 +38.6% | 11 qtrs — |
| 7 | UBS GROUP AG | 5.10M -91.6K (-1.8%) | 28.93M +1.0M (+3.7%) | 1.66% -0.040 pp | 0.00% +0.000 pp | USD5.45 +4.0% | 36 qtrs — |
| 8 | AVORO CAPITAL ADVISORS LLC | 4.44M -24.4K (-0.5%) | 25.20M +1.2M (+5.0%) | 1.45% -0.017 pp | 0.24% -0.068 pp | USD3.81 +48.8% | 21 qtrs — |
| 9 | MORGAN STANLEY | 4.44M +593.5K (+15.4%) | 25.20M +4.5M (+21.9%) | 1.45% +0.186 pp | 0.00% +0.000 pp | USD4.69 +20.9% | 36 qtrs — |
| 10 | DIMENSIONAL FUND ADVISORS LP | 4.44M +426.9K (+10.6%) | 25.20M +3.6M (+16.8%) | 1.45% +0.131 pp | 0.01% +0.001 pp | USD5.72 -0.9% | 7 qtrs — |
| 11 | FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 4.23M +4.2M (+100.0%) | 23.96M +24.0M (+100.0%) | 1.38% +1.377 pp | 0.64% +0.643 pp | USD5.67 +0.0% | 1 qtrs NEW |
| 12 | FMR LLC | 3.58M +258.8K (+7.8%) | 20.28M +2.5M (+13.8%) | 1.17% +0.078 pp | 0.00% +0.000 pp | USD2.85 +98.9% | 33 qtrs — |
| 13 | CITADEL ADVISORS LLC | 3.57M +2.3M (+174.6%) | 20.25M +13.3M (+190.0%) | 1.16% +0.738 pp | 0.00% +0.002 pp | USD5.53 +2.5% | 31 qtrs — |
| 14 | WELLINGTON MANAGEMENT GROUP LLP | 3.31M -162.7K (-4.7%) | 18.74M +117.8K (+0.6%) | 1.08% -0.060 pp | 0.00% +0.000 pp | USD5.11 +11.0% | 9 qtrs — |
| 15 | TSP CAPITAL MANAGEMENT GROUP, LLC | 2.96M -20.8K (-0.7%) | 16.80M +777.3K (+4.9%) | 0.97% -0.013 pp | 4.11% -0.183 pp | USD4.84 +17.1% | 8 qtrs — |
| 16 | 180 WEALTH ADVISORS, LLC | 2.96M +86.7K (+3.0%) | 16.78M +1.4M (+8.8%) | 0.96% +0.023 pp | 1.91% +0.031 pp | USD3.88 +46.1% | 33 qtrs — |
| 17 | NORTHERN TRUST CORP | 2.63M -145.0K (-5.2%) | 14.91M +10.2K (+0.1%) | 0.86% -0.053 pp | 0.00% +0.000 pp | USD3.29 +72.3% | 36 qtrs — |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.56M -13.8K (-0.5%) | 14.54M +695.3K (+5.0%) | 0.84% -0.010 pp | 0.00% +0.000 pp | USD2.90 +95.5% | 36 qtrs — |
| 19 | BANK OF AMERICA CORP /DE/ | 2.36M -585.3K (-19.9%) | 13.39M -2.4M (-15.4%) | 0.77% -0.197 pp | 0.00% 0.000 pp | USD5.49 +3.3% | 36 qtrs — |
| 20 | NUVEEN, LLC | 2.16M -469.6K (-17.8%) | 12.26M -1.9M (-13.3%) | 0.70% -0.158 pp | 0.00% -0.001 pp | USD5.03 +12.7% | 4 qtrs — |
| 21 | GOLDMAN SACHS GROUP INC | 1.92M -27.9K (-1.4%) | 10.90M +426.5K (+4.1%) | 0.63% -0.013 pp | 0.00% +0.000 pp | USD4.90 +15.7% | 36 qtrs — |
| 22 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.89M +200.0K (+11.8%) | 10.74M +1.6M (+18.1%) | 0.62% +0.062 pp | 0.02% +0.002 pp | USD5.40 +5.0% | 2 qtrs — |
| 23 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.88M +676.8K (+56.1%) | 10.67M +4.2M (+64.9%) | 0.61% +0.218 pp | 0.00% +0.001 pp | USD5.55 +2.2% | 36 qtrs — |
| 24 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1.86M +626.9K (+50.8%) | 10.55M +3.9M (+59.2%) | 0.61% +0.202 pp | 0.04% +0.015 pp | USD5.52 +2.7% | 13 qtrs — |
| 25 | EVERSEPT PARTNERS, LP | 1.85M -190.2K (-9.3%) | 10.50M -465.4K (-4.2%) | 0.60% -0.066 pp | 0.53% -0.227 pp | USD5.02 +12.9% | 8 qtrs — |
| 26 | QUBE RESEARCH & TECHNOLOGIES LTD | 1.83M -769.0K (-29.6%) | 10.38M -3.6M (-25.6%) | 0.60% -0.256 pp | 0.01% -0.004 pp | USD5.22 +8.6% | 14 qtrs — |
| 27 | RENAISSANCE TECHNOLOGIES LLC | 1.76M +906.7K (+106.6%) | 9.96M +5.4M (+118.1%) | 0.57% +0.294 pp | 0.02% +0.009 pp | USD5.73 -1.0% | 16 qtrs — |
| 28 | ECOR1 CAPITAL, LLC | 1.66M +1.7M (+100.0%) | 9.41M +9.4M (+100.0%) | 0.54% +0.541 pp | 0.43% +0.427 pp | USD5.67 +0.0% | 1 qtrs NEW |
| 29 | INVESCO LTD. | 1.58M -55.2K (-3.4%) | 8.96M +177.9K (+2.0%) | 0.52% -0.021 pp | 0.00% +0.000 pp | USD4.26 +33.1% | 24 qtrs — |
| 30 | WELLS FARGO & COMPANY/MN | 1.25M -291.1K (-18.9%) | 7.08M -1.2M (-14.4%) | 0.41% -0.098 pp | 0.00% 0.000 pp | USD5.10 +11.2% | 36 qtrs — |
| 31 | APIS CAPITAL ADVISORS, LLC | 1.20M +1.2M (+100.0%) | 6.80M +6.8M (+100.0%) | 0.39% +0.391 pp | 1.19% +1.186 pp | USD5.67 +0.0% | 1 qtrs NEW |
| 32 | TWO SIGMA INVESTMENTS, LP | 1.19M -821.8K (-40.9%) | 6.74M -4.1M (-37.6%) | 0.39% -0.272 pp | 0.01% -0.007 pp | USD4.76 +19.1% | 15 qtrs — |
| 33 | UBS ASSET MANAGEMENT AMERICAS INC | 1.09M +587.2K (+117.0%) | 6.17M +3.5M (+129.1%) | 0.36% +0.190 pp | 0.00% +0.001 pp | USD5.09 +11.4% | 19 qtrs — |
| 34 | AXIOM INVESTORS LLC /DE | 1.04M +138.3K (+15.4%) | 5.88M +1.1M (+21.8%) | 0.34% +0.043 pp | 0.05% +0.016 pp | USD5.41 +4.8% | 2 qtrs — |
| 35 | BARCLAYS PLC | 1.03M +505.6K (+97.3%) | 5.81M +2.5M (+77.8%) | 0.33% +0.164 pp | 0.00% +0.001 pp | USD5.03 +12.7% | 36 qtrs — |
| 36 | DELTEC ASSET MANAGEMENT LLC | 974.7K +251.2K (+34.7%) | 5.53M +1.6M (+42.2%) | 0.32% +0.080 pp | 0.92% +0.275 pp | USD5.45 +4.0% | 2 qtrs — |
| 37 | JACOBS LEVY EQUITY MANAGEMENT, INC | 894.2K -703.5K (-44.0%) | 5.07M -3.5M (-40.9%) | 0.29% -0.233 pp | 0.02% -0.015 pp | USD6.20 -8.5% | 6 qtrs — |
| 38 | BANK OF NEW YORK MELLON CORP | 873.5K -20.8K (-2.3%) | 4.95M +150.2K (+3.1%) | 0.28% -0.009 pp | 0.00% 0.000 pp | USD3.46 +63.9% | 36 qtrs — |
| 39 | DEUTSCHE BANK AG\ | 843.0K +365.8K (+76.7%) | 4.78M +2.2M (+86.5%) | 0.27% +0.118 pp | 0.00% +0.001 pp | USD5.04 +12.5% | 36 qtrs — |
| 40 | SCHRODER INVESTMENT MANAGEMENT GROUP | 827.9K +342.8K (+70.7%) | 4.69M +2.1M (+79.9%) | 0.27% +0.111 pp | 0.00% +0.002 pp | USD5.49 +3.3% | 2 qtrs — |
| 41 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 707.1K +707.1K (+100.0%) | 4.01M +4.0M (+100.0%) | 0.23% +0.231 pp | 0.01% +0.007 pp | USD5.67 +0.0% | 1 qtrs NEW |
| 42 | SCOPIA CAPITAL MANAGEMENT LP | 695.0K +— (+0.0%) | 3.94M +208.5K (+5.6%) | 0.23% -0.001 pp | 0.81% +0.345 pp | USD3.74 +51.6% | 36 qtrs — |
| 43 | APOLLO MANAGEMENT HOLDINGS, L.P. | 664.1K +— (+0.0%) | 3.77M +199.2K (+5.6%) | 0.22% -0.001 pp | 0.03% -0.008 pp | USD4.19 +35.3% | 17 qtrs — |
| 44 | PARKMAN HEALTHCARE PARTNERS LLC | 640.4K -15.7K (-2.4%) | 3.63M +107.6K (+3.1%) | 0.21% -0.006 pp | 0.35% -0.022 pp | USD4.61 +23.0% | 25 qtrs — |
| 45 | AQR CAPITAL MANAGEMENT LLC | 639.2K -97.4K (-13.2%) | 3.62M -331.4K (-8.4%) | 0.21% -0.033 pp | 0.00% -0.001 pp | USD5.24 +8.2% | 22 qtrs — |
| 46 | FIRST TRUST ADVISORS LP | 587.2K +587.2K (+100.0%) | 3.33M +3.3M (+100.0%) | 0.19% +0.191 pp | 0.00% +0.002 pp | USD5.67 +0.0% | 5 qtrs — |
| 47 | RUSSELL INVESTMENTS GROUP, LTD. | 578.4K +144.6K (+33.3%) | 3.28M +949.8K (+40.8%) | 0.19% +0.046 pp | 0.00% +0.001 pp | USD5.67 +0.0% | 17 qtrs — |
| 48 | SWISS NATIONAL BANK | 574.7K +14.8K (+2.6%) | 3.26M +251.9K (+8.4%) | 0.19% +0.004 pp | 0.00% +0.000 pp | USD5.20 +9.0% | 19 qtrs — |
| 49 | D. E. SHAW & CO., INC. | 553.8K -303.2K (-35.4%) | 3.14M -1.5M (-31.8%) | 0.18% -0.101 pp | 0.00% -0.001 pp | USD5.00 +13.4% | 16 qtrs — |
| 50 | DIADEMA PARTNERS LP | 552.3K -487.2K (-46.9%) | 3.13M -2.5M (-43.9%) | 0.18% -0.161 pp | 0.54% -0.888 pp | USD5.20 +9.0% | 4 qtrs — |
| 51 | JANE STREET GROUP, LLC | 548.3K +173.0K (+46.1%) | 3.11M +1.1M (+54.3%) | 0.18% +0.056 pp | 0.00% +0.000 pp | USD5.46 +3.8% | 28 qtrs — |
| 52 | 1492 CAPITAL MANAGEMENT LLC | 535.3K +31.0K (+6.2%) | 3.03M +327.2K (+12.1%) | 0.17% +0.009 pp | 1.16% +0.067 pp | USD4.18 +35.6% | 22 qtrs — |
| 53 | JPMORGAN CHASE & CO | 522.2K -1.5M (-74.5%) | 2.96M -8.0M (-73.1%) | 0.17% -0.501 pp | 0.00% -0.001 pp | USD4.99 +13.6% | 36 qtrs — |
| 54 | MILLENNIUM MANAGEMENT LLC | 512.7K -73.8K (-12.6%) | 2.91M -242.5K (-7.7%) | 0.17% -0.025 pp | 0.00% 0.000 pp | USD5.40 +5.0% | 36 qtrs — |
| 55 | TWO SIGMA ADVISERS, LP | 511.0K -1.3M (-72.1%) | 2.90M -6.9M (-70.5%) | 0.17% -0.434 pp | 0.01% -0.014 pp | USD5.26 +7.8% | 23 qtrs — |
| 56 | SCHONFELD STRATEGIC ADVISORS LLC | 484.2K +310.9K (+179.4%) | 2.75M +1.8M (+195.0%) | 0.16% +0.101 pp | 0.01% +0.007 pp | USD5.21 +8.8% | 26 qtrs — |
| 57 | SEI INVESTMENTS CO | 472.9K +370.6K (+362.2%) | 2.68M +2.1M (+388.0%) | 0.15% +0.121 pp | 0.00% +0.002 pp | USD5.63 +0.7% | 10 qtrs — |
| 58 | RAFFERTY ASSET MANAGEMENT, LLC | 452.5K +243.0K (+116.0%) | 2.57M +1.4M (+128.1%) | 0.15% +0.079 pp | 0.01% +0.005 pp | USD4.63 +22.5% | 21 qtrs — |
| 59 | TREXQUANT INVESTMENT LP | 446.9K +446.9K (+100.0%) | 2.53M +2.5M (+100.0%) | 0.15% +0.146 pp | 0.02% +0.023 pp | USD5.67 +0.0% | 6 qtrs — |
| 60 | BNP PARIBAS ARBITRAGE, SNC | 432.8K -125.5K (-22.5%) | 2.45M -544.0K (-18.1%) | 0.14% -0.042 pp | 0.00% -0.001 pp | USD5.95 -4.7% | 36 qtrs — |
| 61 | SQUAREPOINT OPS LLC | 427.1K -1.3M (-75.1%) | 2.42M -6.8M (-73.7%) | 0.14% -0.423 pp | 0.00% -0.007 pp | USD5.22 +8.6% | 23 qtrs — |
| 62 | VICTORY CAPITAL MANAGEMENT INC | 405.7K -6.7K (-1.6%) | 2.30M +85.6K (+3.9%) | 0.13% -0.003 pp | 0.00% +0.000 pp | USD5.07 +11.8% | 26 qtrs — |
| 63 | RHUMBLINE ADVISERS | 381.4K -60.4K (-13.7%) | 2.16M -209.7K (-8.8%) | 0.12% -0.021 pp | 0.00% 0.000 pp | USD3.34 +69.8% | 31 qtrs — |
| 64 | RAYMOND JAMES FINANCIAL INC | 375.6K -223.6K (-37.3%) | 2.13M -1.1M (-33.8%) | 0.12% -0.074 pp | 0.00% 0.000 pp | USD6.35 -10.7% | 5 qtrs — |
| 65 | CALAMOS ADVISORS LLC | 370.7K +139.8K (+60.5%) | 2.10M +862.0K (+69.5%) | 0.12% +0.045 pp | 0.01% +0.003 pp | USD5.48 +3.5% | 2 qtrs — |
| 66 | PRINCIPAL FINANCIAL GROUP INC | 333.8K +101.1K (+43.5%) | 1.89M +643.2K (+51.5%) | 0.11% +0.033 pp | 0.00% +0.000 pp | USD5.67 +0.0% | 31 qtrs — |
| 67 | PRICE T ROWE ASSOCIATES INC /MD/ | 307.2K +39.2K (+14.6%) | 1.74M +303.0K (+21.1%) | 0.10% +0.012 pp | 0.00% +0.000 pp | USD4.41 +28.6% | 25 qtrs — |
| 68 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 300.5K +300.5K (+100.0%) | 1.70M +1.7M (+100.0%) | 0.10% +0.098 pp | 0.00% +0.001 pp | USD5.67 +0.0% | 10 qtrs — |
| 69 | LEGAL & GENERAL GROUP PLC | 294.0K -25.2K (-7.9%) | 1.67M -47.0K (-2.7%) | 0.10% -0.009 pp | 0.00% +0.000 pp | USD4.22 +34.4% | 31 qtrs — |
| 70 | ALLIANCEBERNSTEIN L.P. | 278.9K -241.0 (-0.1%) | 1.58M +82.4K (+5.5%) | 0.09% -0.001 pp | 0.00% +0.000 pp | USD3.14 +80.6% | 31 qtrs — |
| 71 | VOLEON CAPITAL MANAGEMENT LP | 269.8K +32.6K (+13.7%) | 1.53M +255.8K (+20.1%) | 0.09% +0.010 pp | 0.03% +0.002 pp | USD5.41 +4.8% | 2 qtrs — |
| 72 | MARSHALL WACE, LLP | 264.3K +264.3K (+100.0%) | 1.50M +1.5M (+100.0%) | 0.09% +0.086 pp | 0.00% +0.001 pp | USD5.67 +0.0% | 12 qtrs — |
| 73 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 255.6K -1.1K (-0.4%) | 1.45M +70.6K (+5.1%) | 0.08% -0.001 pp | 0.00% +0.000 pp | USD2.00 +183.5% | 31 qtrs — |
| 74 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 245.3K +245.3K (+100.0%) | 1.39M +1.4M (+100.0%) | 0.08% +0.080 pp | 0.01% +0.011 pp | USD5.67 +0.0% | 16 qtrs — |
| 75 | Y-INTERCEPT (HONG KONG) LTD | 238.7K +238.7K (+100.0%) | 1.35M +1.4M (+100.0%) | 0.08% +0.078 pp | 0.03% +0.030 pp | USD5.67 +0.0% | 1 qtrs NEW |
| 76 | AQUATIC CAPITAL MANAGEMENT LLC | 222.2K +167.1K (+303.6%) | 1.26M +964.1K (+326.2%) | 0.07% +0.054 pp | 0.04% +0.030 pp | USD5.60 +1.3% | 2 qtrs — |
| 77 | MARINER, LLC | 209.5K +2.8K (+1.3%) | 1.19M +77.7K (+7.0%) | 0.07% +0.001 pp | 0.00% +0.000 pp | USD6.42 -11.7% | 5 qtrs — |
| 78 | ROYAL BANK OF CANADA | 206.6K +4.2K (+2.1%) | 1.17M +83.0K (+7.6%) | 0.07% +0.001 pp | 0.00% +0.000 pp | USD4.07 +39.3% | 36 qtrs — |
| 79 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 204.1K +16.4K (+8.7%) | 1.16M +148.8K (+14.8%) | 0.07% +0.005 pp | 0.00% +0.000 pp | USD5.25 +8.0% | 7 qtrs — |
| 80 | AARON WEALTH ADVISORS LLC | 200.8K +2.4K (+1.2%) | 1.14M +72.9K (+6.8%) | 0.07% +0.000 pp | 0.06% -0.001 pp | USD5.01 +13.2% | 13 qtrs — |
| 81 | BRUCE & CO., INC. | 195.1K +— (+0.0%) | 1.11M +58.5K (+5.6%) | 0.06% 0.000 pp | 0.34% +0.019 pp | USD3.84 +47.7% | 26 qtrs — |
| 82 | BALYASNY ASSET MANAGEMENT L.P. | 195.0K +82.5K (+73.3%) | 1.11M +501.3K (+83.0%) | 0.06% +0.027 pp | 0.00% +0.001 pp | USD5.72 -0.9% | 5 qtrs — |
| 83 | MAN GROUP PLC | 178.5K +79.8K (+80.9%) | 1.01M +482.3K (+91.0%) | 0.06% +0.026 pp | 0.00% +0.001 pp | USD5.24 +8.2% | 9 qtrs — |
| 84 | CREATIVE PLANNING | 171.8K -7.8K (-4.3%) | 973.9K +9.7K (+1.0%) | 0.06% -0.003 pp | 0.00% +0.000 pp | USD3.96 +43.2% | 36 qtrs — |
| 85 | PROFUND ADVISORS LLC | 169.0K +120.2K (+246.5%) | 958.2K +696.3K (+265.8%) | 0.06% +0.039 pp | 0.03% +0.021 pp | USD5.22 +8.6% | 12 qtrs — |
| 86 | FRANKLIN RESOURCES INC | 163.3K +1.1K (+0.7%) | 925.8K +54.7K (+6.3%) | 0.05% +0.000 pp | 0.00% +0.000 pp | USD4.31 +31.6% | 11 qtrs — |
| 87 | STATE OF WISCONSIN INVESTMENT BOARD | 162.0K -9.8K (-5.7%) | 918.3K -4.3K (-0.5%) | 0.05% -0.004 pp | 0.00% 0.000 pp | USD5.07 +11.8% | 30 qtrs — |
| 88 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | 161.3K +— (+0.0%) | 915.0K +49.0K (+5.7%) | 0.05% 0.000 pp | 0.01% +0.000 pp | USD5.37 +5.6% | 2 qtrs — |
| 89 | METLIFE INVESTMENT MANAGEMENT, LLC | 154.3K -16.8K (-9.8%) | 874.6K -43.7K (-4.8%) | 0.05% -0.006 pp | 0.00% 0.000 pp | USD3.65 +55.3% | 28 qtrs — |
| 90 | SG AMERICAS SECURITIES, LLC | 143.6K +63.7K (+79.6%) | 814.0K +385.0K (+89.7%) | 0.05% +0.021 pp | 0.00% 0.000 pp | USD5.52 +2.7% | 28 qtrs — |
| 91 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 140.4K -8.8K (-5.9%) | 796.3K -4.9K (-0.6%) | 0.05% -0.003 pp | 0.00% +0.000 pp | USD3.70 +53.2% | 36 qtrs — |
| 92 | JANUS HENDERSON GROUP PLC | 127.8K +— (+0.0%) | 723.8K +37.1K (+5.4%) | 0.04% 0.000 pp | 0.00% +0.000 pp | USD4.61 +23.0% | 18 qtrs — |
| 93 | INTECH INVESTMENT MANAGEMENT LLC | 127.4K +— (+0.0%) | 722.1K +38.2K (+5.6%) | 0.04% 0.000 pp | 0.01% +0.000 pp | USD5.39 +5.2% | 6 qtrs — |
| 94 | BREVAN HOWARD CAPITAL MANAGEMENT LP | 122.6K +122.6K (+100.0%) | 695.2K +695.2K (+100.0%) | 0.04% +0.040 pp | 0.01% +0.008 pp | USD5.67 +0.0% | 1 qtrs NEW |
| 95 | WALLEYE CAPITAL LLC | 121.1K +121.1K (+100.0%) | 686.9K +686.9K (+100.0%) | 0.04% +0.040 pp | 0.00% +0.002 pp | USD5.67 +0.0% | 1 qtrs NEW |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 97 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | ALPS Medical Breakthroughs ETF SBIO | 0.65% | 1.37M | 0.50% |
| 2 | Janus Henderson Small/Mid Cap Growth Alpha ETF JSMD | 0.62% | 6.70M | 0.30% |
| 3 | Invesco NASDAQ Future Gen 200 ETF QQQS | 0.54% | 119.0K | 0.20% |
| 4 | Janus Henderson Small Cap Growth Alpha ETF JSML | 0.49% | 1.81M | 0.30% |
| 5 | Global X - Aging Population ETF AGNG | 0.48% | 408.2K | 0.50% |
| 6 | VictoryShares Small Cap Free Cash Flow ETF SFLO | 0.40% | 2.53M | 0.56% |
| 7 | Global X - S&P Biotech ETF CURE.AX | 0.32% | 116.3K | 0.45% |
| 8 | State Street SPDR S&P Biotech ETF XBI | 0.32% | 34.93M | 0.35% |
| 9 | Goldman Sachs Innovate Equity ETF GINN | 0.13% | 264.0K | 0.50% |
| 10 | First Trust Small Cap Core AlphaDEX Fund FYX | 0.12% | 1.67M | 0.58% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
14.00
Bullish
Ratio by volume
3.00
Bullish
Buys
14
Sells
1
Shares acquired
478.5K
Shares disposed
47.0K
Cash buys
1.00
Cash sales
1.00
Net activity
+431,542
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-22 | Prentiss Christopher B | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 12,267 | 2.74 | 33.6K | 338,924 | D | ↗ |
| 2026-03-23 | Tross Stuart A | Officer | A-Award | A | Performance Restricted Stock Unit | 221,000 | 0.00 | — | 221,000 | D | ↗ |
| 2026-03-23 | Thomson David | Officer | A-Award | A | Employee Stock Option (right to buy) | 217,000 | 2.44 | 529.5K | 217,000 | D | ↗ |
| 2026-03-23 | Singh Sanjay R | Officer | A-Award | A | Employee Stock Option (right to buy) | 217,000 | 2.44 | 529.5K | 217,000 | D | ↗ |
| 2026-03-23 | Prentiss Christopher B | Officer | A-Award | A | Employee Stock Option (right to buy) | 217,000 | 2.44 | 529.5K | 217,000 | D | ↗ |
| 2026-03-23 | Castagna Michael | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 782,000 | 2.44 | 1.91M | 782,000 | D | ↗ |
| 2026-03-23 | Ahuja Ajay | Officer | A-Award | A | Employee Stock Option (right to buy) | 217,000 | 2.44 | 529.5K | 217,000 | D | ↗ |
| 2026-03-10 | Castagna Michael | Director / Officer | P-Purchase | A | Common Stock, $0.01 Par Value | 100,000 | 2.59 | 259.0K | 2,575,911 | D | ↗ |
| 2026-03-01 | Tross Stuart A | Officer | A-Award | A | Common Stock, $0.01 Par Value | 15,290 | 3.27 | 50.0K | 1,000,297 | D | ↗ |
| 2026-03-01 | Shannon James Samuel | Director | A-Award | A | Common Stock, $0.01 Par Value | 12,000 | 3.27 | 39.2K | 64,635 | D | ↗ |
| 2026-03-01 | Prentiss Christopher B | Officer | A-Award | A | Common Stock, $0.01 Par Value | 5,000 | 3.27 | 16.4K | 348,854 | D | ↗ |
| 2026-03-01 | HOOPER ANTHONY C | Director | A-Award | A | Common Stock, $0.01 Par Value | 35,000 | 3.27 | 114.5K | 236,153 | D | ↗ |
| 2026-03-01 | Castagna Michael | Director / Officer | A-Award | A | Common Stock, $0.01 Par Value | 15,290 | 3.27 | 50.0K | 2,475,911 | D | ↗ |
| 2026-02-26 | Tross Stuart A | Officer | A-Award | A | Employee Stock Option (right to buy) | 20,000 | 4.55 | 91.0K | 20,000 | D | ↗ |
| 2026-02-26 | Thomson David | Officer | A-Award | A | Employee Stock Option (right to buy) | 37,525 | 1.42 | 53.3K | 37,525 | D | ↗ |
| 2026-02-26 | Castagna Michael | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 37,525 | 1.42 | 53.3K | 37,525 | D | ↗ |
| 2026-02-26 | Binder Steven B. | Director | A-Award | A | Employee Stock Option (right to buy) | 45,025 | 1.47 | 66.2K | 45,025 | D | ↗ |
| 2026-01-08 | Tross Stuart A | Officer | S-Sale | D | Common Stock, $0.01 Par Value | 47,006 | 6.33 | 297.5K | 985,007 | D | ↗ |
| 2025-12-24 | Castagna Michael | Director / Officer | G-Gift | D | Common Stock, $0.01 Par Value | 44,171 | 0.00 | — | 2,460,621 | D | ↗ |
| 2025-12-17 | Castagna Michael | Director / Officer | M-Exempt | A | Common Stock, $0.01 Par Value | 65,804 | 4.55 | 299.4K | 2,570,596 | D | ↗ |
| 2025-12-16 | Castagna Michael | Director / Officer | S-Sale | D | Common Stock, $0.01 Par Value | 21,310 | 6.00 | 127.9K | 2,504,792 | D | ↗ |
| 2025-12-12 | Castagna Michael | Director / Officer | M-Exempt | A | Common Stock, $0.01 Par Value | 20,806 | 4.55 | 94.7K | 2,525,598 | D | ↗ |
| 2025-12-02 | Thomson David | Officer | M-Exempt | A | Common Stock, $0.01 Par Value | 87,780 | 4.60 | 403.8K | 989,499 | D | ↗ |
| 2025-12-02 | Castagna Michael | Director / Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 65,840 | 4.55 | 299.6K | 0 | D | ↗ |
| 2025-11-14 | Singh Sanjay R | Officer | S-Sale | D | Common Stock, $0.01 Par Value | 18,777 | 5.03 | 94.4K | 455,211 | D | ↗ |
| 2025-11-11 | Ahuja Ajay | Officer | A-Award | A | Common Stock, $0.01 Par Value | 318,200 | 0.00 | — | 318,200 | D | ↗ |
| 2025-10-31 | Singh Sanjay R | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 17,071 | 5.59 | 95.4K | 473,988 | D | ↗ |
| 2025-09-29 | Ahuja Ajay | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-09-16 | Tross Stuart A | Officer | S-Sale | D | Common Stock, $0.01 Par Value | 47,000 | 5.34 | 251.0K | 1,032,013 | D | ↗ |
| 2025-08-05 | Tross Stuart A | Officer | A-Award | A | Common Stock, $0.01 Par Value | 12,755 | 3.92 | 50.0K | 1,079,013 | D | ↗ |
| 2025-07-16 | Thomson David | Officer | S-Sale | D | Common Stock, $0.01 Par Value | 7,466 | 3.94 | 29.4K | 841,719 | D | ↗ |
| 2025-07-16 | Binder Steven B. | Director | S-Sale | D | Common Stock, $0.01 Par Value | 75,367 | 3.94 | 296.9K | 830,508 | D | ↗ |
| 2025-07-15 | Tross Stuart A | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 28,057 | 3.85 | 108.0K | 1,066,258 | D | ↗ |
| 2025-07-15 | Thomson David | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 30,361 | 3.85 | 116.9K | 849,185 | D | ↗ |
| 2025-07-15 | Singh Sanjay R | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 15,450 | 3.85 | 59.5K | 491,059 | D | ↗ |
| 2025-07-15 | Sabella Lauren M | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 11,896 | 3.85 | 45.8K | 349,841 | D | ↗ |
| 2025-07-15 | Prentiss Christopher B | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 11,540 | 3.85 | 44.4K | 343,854 | D | ↗ |
| 2025-07-15 | Castagna Michael | Director / Officer | F-InKind | D | Common Stock, $0.01 Par Value | 111,275 | 3.85 | 428.4K | 2,504,792 | D | ↗ |
| 2025-07-15 | Binder Steven B. | Director | F-InKind | D | Common Stock, $0.01 Par Value | 19,383 | 3.85 | 74.6K | 905,875 | D | ↗ |
| 2025-07-15 | BLANK BURKHARD | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 9,556 | 3.85 | 36.8K | 460,791 | D | ↗ |
| 2025-06-23 | Marasco Dominic | Officer | A-Award | A | Performance Restricted Stock Unit | 1,000,000 | 0.00 | — | 1,000,000 | D | ↗ |
| 2025-06-10 | Binder Steven B. | Director | S-Sale | D | Common Stock, $0.01 Par Value | 64,085 | 4.00 | 256.3K | 925,258 | D | ↗ |
| 2025-05-27 | BLANK BURKHARD | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 15,630 | 4.12 | 64.4K | 465,124 | D | ↗ |
| 2025-05-20 | Thomson David | Officer | S-Sale | D | Common Stock, $0.01 Par Value | 2,345 | 4.41 | 10.3K | 879,546 | D | ↗ |
| 2025-05-20 | Binder Steven B. | Director | S-Sale | D | Common Stock, $0.01 Par Value | 12,078 | 4.40 | 53.1K | 989,343 | D | ↗ |
| 2025-05-19 | Tross Stuart A | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 6,147 | 4.37 | 26.9K | 1,090,427 | D | ↗ |
| 2025-05-19 | Thomson David | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 9,536 | 4.37 | 41.7K | 881,891 | D | ↗ |
| 2025-05-19 | Castagna Michael | Director / Officer | F-InKind | D | Common Stock, $0.01 Par Value | 26,114 | 4.37 | 114.1K | 2,612,934 | D | ↗ |
| 2025-05-19 | Binder Steven B. | Director | F-InKind | D | Common Stock, $0.01 Par Value | 5,190 | 4.37 | 22.7K | 1,001,421 | D | ↗ |
| 2025-05-14 | Shannon James Samuel | Director | A-Award | A | Restricted Stock Unit | 52,854 | 0.00 | — | 52,854 | D | ↗ |
| 2025-05-14 | Marasco Dominic | Officer | A-Award | A | Performance Restricted Stock Unit | 72,500 | 0.00 | — | 72,500 | D | ↗ |
| 2025-05-14 | MUNDKUR CHRISTINE | Director | A-Award | A | Restricted Stock Unit | 52,854 | 0.00 | — | 52,854 | D | ↗ |
| 2025-05-14 | Kay Sabrina | Director | A-Award | A | Restricted Stock Unit | 10,571 | 0.00 | — | 10,571 | D | ↗ |
| 2025-05-14 | HOOPER ANTHONY C | Director | A-Award | A | Restricted Stock Unit | 10,571 | 0.00 | — | 10,571 | D | ↗ |
| 2025-05-14 | Grancio Jennifer | Director | A-Award | A | Restricted Stock Unit | 52,854 | 0.00 | — | 52,854 | D | ↗ |
| 2025-05-14 | Friedman Michael A | Director | A-Award | A | Restricted Stock Unit | 52,854 | 0.00 | — | 52,854 | D | ↗ |
| 2025-05-14 | Castagna Michael | Director / Officer | A-Award | A | Common Stock, $0.01 Par Value | 27,000 | 4.56 | 123.1K | 2,639,048 | D | ↗ |
| 2025-05-14 | CONSIGLIO RONALD J | Director | A-Award | A | Restricted Stock Unit | 52,854 | 0.00 | — | 52,854 | D | ↗ |
| 2025-05-14 | Binder Steven B. | Director | A-Award | A | Restricted Stock Unit | 52,854 | 0.00 | — | 52,854 | D | ↗ |
| 2025-05-13 | Tross Stuart A | Officer | A-Award | A | Performance Restricted Stock Unit | 145,000 | 0.00 | — | 145,000 | D | ↗ |
| 2025-05-13 | Thomson David | Officer | A-Award | A | Common Stock, $0.01 Par Value | 119,000 | 0.00 | — | 891,427 | D | ↗ |
| 2025-05-13 | Singh Sanjay R | Officer | A-Award | A | Performance Restricted Stock Unit | 145,000 | 0.00 | — | 145,000 | D | ↗ |
| 2025-05-13 | Prentiss Christopher B | Officer | A-Award | A | Performance Restricted Stock Unit | 145,000 | 0.00 | — | 145,000 | D | ↗ |
| 2025-05-13 | Castagna Michael | Director / Officer | A-Award | A | Performance Restricted Stock Unit | 523,000 | 0.00 | — | 523,000 | D | ↗ |
| 2025-05-13 | Binder Steven B. | Director | S-Sale | D | Common Stock, $0.01 Par Value | 80,144 | 4.69 | 375.9K | 1,006,611 | D | ↗ |
| 2025-05-12 | Tross Stuart A | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 8,051 | 4.56 | 36.7K | 976,016 | D | ↗ |
| 2025-05-12 | Thomson David | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 12,364 | 4.56 | 56.4K | 804,606 | D | ↗ |
| 2025-05-12 | Castagna Michael | Director / Officer | F-InKind | D | Common Stock, $0.01 Par Value | 34,894 | 4.56 | 159.1K | 2,184,048 | D | ↗ |
| 2025-05-12 | Binder Steven B. | Director | F-InKind | D | Common Stock, $0.01 Par Value | 6,441 | 4.56 | 29.4K | 1,086,755 | D | ↗ |
| 2025-05-10 | Tross Stuart A | Officer | A-Award | A | Common Stock, $0.01 Par Value | 105,600 | 0.00 | — | 1,072,791 | D | ↗ |
| 2025-05-10 | Thomson David | Officer | A-Award | A | Common Stock, $0.01 Par Value | 105,600 | 0.00 | — | 935,443 | D | ↗ |
| 2025-05-10 | Castagna Michael | Director / Officer | A-Award | A | Common Stock, $0.01 Par Value | 298,560 | 0.00 | — | 2,553,896 | D | ↗ |
| 2025-05-10 | Binder Steven B. | Director | A-Award | A | Common Stock, $0.01 Par Value | 105,600 | 0.00 | — | 1,180,626 | D | ↗ |
| 2025-04-04 | Castagna Michael | Director / Officer | J-Other | D | Common Stock, $0.01 Par Value | 39,500 | 0.00 | — | 2,255,336 | D | ↗ |
| 2025-03-27 | Sabella Lauren M | Officer | F-InKind | D | Common Stock, $.01 Par Value | 16,407 | 5.10 | 83.7K | 357,849 | D | ↗ |
| 2025-02-12 | Marasco Dominic | Officer | A-Award | A | Common Stock, $0.01 Par Value | 252,000 | 0.00 | — | 252,000 | D | ↗ |
| 2025-01-06 | Marasco Dominic | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-11-22 | Binder Steven B. | Director | M-Exempt | A | Common Stock, $0.01 Par Value | 67,536 | 1.47 | 99.3K | 1,142,562 | D | ↗ |
| 2024-11-18 | Binder Steven B. | Director | A-Award | A | Deferred Restricted Stock Unit | 17,575 | 0.00 | — | 17,575 | D | ↗ |
| 2024-11-15 | Binder Steven B. | Director | M-Exempt | D | Employee Stock Option (Right to Buy) | 22,513 | 1.47 | 33.1K | 22,512 | D | ↗ |
| 2024-11-06 | Tross Stuart A | Officer | S-Sale | D | Common Stock, $0.01 Par Value | 55,000 | 7.34 | 403.7K | 967,191 | D | ↗ |
| 2024-10-31 | Singh Sanjay R | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 17,071 | 7.07 | 120.7K | 385,416 | D | ↗ |
| 2024-09-03 | Tross Stuart A | Officer | S-Sale | D | Common Stock, $0.01 Par Value | 25,000 | 6.26 | 156.5K | 1,022,191 | — | ↗ |
| 2024-08-30 | Tross Stuart A | Officer | S-Sale | D | Common Stock, $0.01 Par Value | 45,000 | 6.33 | 284.9K | 1,082,191 | — | ↗ |
| 2024-08-29 | Thomson David | Officer | S-Sale | D | Common Stock, $0.01 Par Value | 5,553 | 5.94 | 33.0K | 829,843 | — | ↗ |
| 2024-08-29 | Castagna Michael | Director / Officer | G-Gift | D | Common Stock, $0.01 Par Value | 19,000 | 0.00 | — | 2,379,942 | — | ↗ |
| 2024-08-29 | Binder Steven B. | Officer | S-Sale | D | Common Stock, $0.01 Par Value | 5,055 | 5.94 | 30.0K | 1,075,026 | — | ↗ |
| 2024-08-28 | Castagna Michael | Director / Officer | G-Gift | D | Common Stock, $0.01 Par Value | 13,894 | 0.00 | — | 2,398,942 | — | ↗ |
| 2024-08-27 | Tross Stuart A | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 20,779 | 5.38 | 111.8K | 1,127,191 | — | ↗ |
| 2024-08-27 | Thomson David | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 22,489 | 5.38 | 121.0K | 835,396 | — | ↗ |
| 2024-08-27 | Castagna Michael | Director / Officer | F-InKind | D | Common Stock, $0.01 Par Value | 56,085 | 5.38 | 301.7K | 2,412,836 | — | ↗ |
| 2024-08-27 | Binder Steven B. | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 20,779 | 5.38 | 111.8K | 1,080,081 | — | ↗ |
| 2024-07-16 | Thomson David | Officer | S-Sale | D | Common Stock, $0.01 Par Value | 3,115 | 5.93 | 18.5K | 857,885 | — | ↗ |
| 2024-07-16 | Binder Steven B. | Officer | S-Sale | D | Common Stock, $0.01 Par Value | 2,836 | 5.93 | 16.8K | 1,100,860 | — | ↗ |
| 2024-07-15 | Tross Stuart A | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 11,657 | 5.83 | 68.0K | 1,147,970 | — | ↗ |
| 2024-07-15 | Thomson David | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 12,616 | 5.83 | 73.6K | 861,000 | — | ↗ |
| 2024-07-15 | Singh Sanjay R | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 5,372 | 5.83 | 31.3K | 402,487 | — | ↗ |
| 2024-07-15 | Sabella Lauren M | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 1,817 | 5.83 | 10.6K | 374,256 | — | ↗ |
| 2024-07-15 | Castagna Michael | Director / Officer | F-InKind | D | Common Stock, $0.01 Par Value | 47,309 | 5.83 | 275.8K | 2,468,921 | — | ↗ |
| 2024-07-15 | Binder Steven B. | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 11,657 | 5.83 | 68.0K | 1,103,696 | — | ↗ |
| 2024-06-30 | Tross Stuart A | Officer | A-Award | A | Common Stock, $0.01 Par Value | 4,689 | 3.09 | 14.5K | 1,159,627 | — | ↗ |
| 2024-06-30 | Singh Sanjay R | Officer | A-Award | A | Common Stock, $0.01 Par Value | 3,362 | 3.09 | 10.4K | 407,859 | — | ↗ |
| 2024-06-30 | Sabella Lauren M | Officer | A-Award | A | Common Stock, $0.01 Par Value | 722 | 3.09 | 2.2K | 376,073 | — | ↗ |
| 2024-06-30 | Castagna Michael | Director / Officer | A-Award | A | Common Stock, $0.01 Par Value | 5,000 | 3.09 | 15.5K | 2,516,230 | — | ↗ |
| 2024-06-30 | Binder Steven B. | Officer | A-Award | A | Common Stock, $0.01 Par Value | 800 | 3.09 | 2.5K | 1,115,353 | — | ↗ |
| 2024-05-24 | BLANK BURKHARD | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-05-21 | Thomson David | Officer | S-Sale | D | Common Stock, $0.01 Par Value | 23,537 | 4.66 | 109.7K | 873,616 | — | ↗ |
| 2024-05-21 | Binder Steven B. | Officer | S-Sale | D | Common Stock, $0.01 Par Value | 25,952 | 4.66 | 120.9K | 1,114,553 | — | ↗ |
| 2024-05-18 | Tross Stuart A | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 6,130 | 4.59 | 28.1K | 1,154,938 | — | ↗ |
| 2024-05-18 | Thomson David | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 6,916 | 4.59 | 31.7K | 897,153 | — | ↗ |
| 2024-05-18 | Castagna Michael | Director / Officer | F-InKind | D | Common Stock, $0.01 Par Value | 26,067 | 4.59 | 119.6K | 2,511,230 | — | ↗ |
| 2024-05-18 | Binder Steven B. | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 6,162 | 4.59 | 28.3K | 1,140,505 | — | ↗ |
| 2024-05-17 | Tross Stuart A | Officer | A-Award | A | Common Stock, $0.01 Par Value | 77,420 | 4.59 | 355.4K | 1,223,124 | — | ↗ |
| 2024-05-17 | Thomson David | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 85,797 | 4.59 | 393.8K | 904,069 | — | ↗ |
| 2024-05-17 | Castagna Michael | Director / Officer | J-Other | D | Common Stock, $.01 Par Value | 24,330 | 4.79 | 116.5K | 2,561,260 | — | ↗ |
| 2024-05-17 | Binder Steven B. | Officer | F-InKind | D | Common Stock, $0.01 Par Value | 63,720 | 4.59 | 292.5K | 1,146,667 | — | ↗ |
| 2024-05-15 | Tross Stuart A | Officer | A-Award | A | Performance Restricted Stock Unit | 158,000 | 0.00 | — | 158,000 | — | ↗ |
| 2024-05-15 | Thomson David | Officer | A-Award | A | Performance Restricted Stock Unit | 158,000 | 0.00 | — | 158,000 | — | ↗ |
| 2024-05-15 | Singh Sanjay R | Officer | A-Award | A | Common Stock, $.01 Par Value | 129,000 | 0.00 | — | 404,497 | — | ↗ |
| 2024-05-15 | Shannon James Samuel | Director | A-Award | A | Restricted Stock Unit | 35,047 | 0.00 | — | 35,047 | — | ↗ |
| 2024-05-15 | Sabella Lauren M | Officer | A-Award | A | Common Stock, $.01 Par Value | 129,000 | 0.00 | — | 375,351 | — | ↗ |
| 2024-05-15 | Prentiss Christopher B | Officer | A-Award | A | Performance Restricted Stock Unit | 158,000 | 0.00 | — | 158,000 | — | ↗ |
| 2024-05-15 | MUNDKUR CHRISTINE | Director | A-Award | A | Restricted Stock Unit | 35,047 | 0.00 | — | 35,047 | — | ↗ |
| 2024-05-15 | Kay Sabrina | Director | A-Award | A | Restricted Stock Unit | 35,047 | 0.00 | — | 35,047 | — | ↗ |
| 2024-05-15 | KRESA KENT | Director | A-Award | A | Restricted Stock Unit | 35,047 | 0.00 | — | 35,047 | — | ↗ |
| 2024-05-15 | HOOPER ANTHONY C | Director | A-Award | A | Restricted Stock Unit | 35,047 | 0.00 | — | 35,047 | — | ↗ |
| 2024-05-15 | Grancio Jennifer | Director | A-Award | A | Restricted Stock Unit | 35,047 | 0.00 | — | 35,047 | — | ↗ |
| 2024-05-15 | Friedman Michael A | Director | A-Award | A | Restricted Stock Unit | 35,047 | 0.00 | — | 35,047 | — | ↗ |
| 2024-05-15 | Castagna Michael | Director / Officer | A-Award | A | Performance Restricted Stock Unit | 569,000 | 0.00 | — | 569,000 | — | ↗ |
| 2024-05-15 | CONSIGLIO RONALD J | Director | A-Award | A | Restricted Stock Unit | 35,047 | 0.00 | — | 35,047 | — | ↗ |
| 2024-05-15 | Binder Steven B. | Officer | A-Award | A | Common Stock, $.01 Par Value | 287,000 | 0.00 | — | 1,132,967 | — | ↗ |
| 2024-05-15 | BLANK BURKHARD | Officer | A-Award | A | Common Stock, $.01 Par Value | 129,000 | 0.00 | — | 496,905 | — | ↗ |
| 2024-05-13 | Thomson David | Officer | S-Sale | D | Common Stock, $.01 Par Value | 3,047 | 4.31 | 13.1K | 783,446 | — | ↗ |
| 2024-05-13 | Binder Steven B. | Officer | S-Sale | D | Common Stock, $.01 Par Value | 3,618 | 4.31 | 15.6K | 845,967 | — | ↗ |
| 2024-05-10 | Tross Stuart A | Officer | F-InKind | D | Common Stock, $.01 Par Value | 8,028 | 4.32 | 34.7K | 1,016,704 | — | ↗ |
| 2024-05-10 | Thomson David | Officer | F-InKind | D | Common Stock, $.01 Par Value | 12,342 | 4.32 | 53.3K | 786,493 | — | ↗ |
| 2024-05-10 | Castagna Michael | Director / Officer | F-InKind | D | Common Stock, $.01 Par Value | 34,830 | 4.32 | 150.5K | 2,149,260 | — | ↗ |
| 2024-05-10 | Binder Steven B. | Officer | F-InKind | D | Common Stock, $.01 Par Value | 8,028 | 4.32 | 34.7K | 849,585 | — | ↗ |
| 2024-04-22 | Prentiss Christopher B | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-03-27 | Sabella Lauren M | Officer | F-InKind | D | Common Stock, $.01 Par Value | 17,084 | 4.63 | 79.1K | 246,351 | — | ↗ |
| 2024-02-04 | Tross Stuart A | Officer | A-Award | A | Common Stock, $0.01 Par Value | 15,290 | 3.27 | 50.0K | 1,024,732 | — | ↗ |
| 2024-02-04 | Sabella Lauren M | Officer | A-Award | A | Common Stock, $0.01 Par Value | 15,290 | 3.27 | 50.0K | 263,435 | — | ↗ |
| 2024-02-04 | Kay Sabrina | Director | A-Award | A | Common Stock, $0.01 Par Value | 107,033 | 3.27 | 350.0K | 265,600 | — | ↗ |
| 2024-02-04 | HOOPER ANTHONY C | Director | A-Award | A | Common Stock, $0.01 Par Value | 40,000 | 3.27 | 130.8K | 176,153 | — | ↗ |
| 2024-02-04 | Castagna Michael | Director / Officer | A-Award | A | Common Stock, $0.01 Par Value | 30,581 | 3.27 | 100.0K | 2,184,090 | — | ↗ |
| 2024-02-04 | CONSIGLIO RONALD J | Director | A-Award | A | Common Stock, $0.01 Par Value | 25,000 | 3.27 | 81.8K | 545,997 | — | ↗ |
| 2024-02-04 | BLANK BURKHARD | Officer | A-Award | A | Common Stock, $0.01 Par Value | 152,905 | 3.27 | 500.0K | 367,905 | — | ↗ |
| 2023-12-31 | Tross Stuart A | Officer | A-Award | A | Common Stock, $0.01 Par Value | 1,006 | 3.09 | 3.1K | 1,009,442 | — | ↗ |
| 2023-12-31 | Sabella Lauren M | Officer | A-Award | A | Common Stock, $0.01 Par Value | 711 | 3.09 | 2.2K | 248,145 | — | ↗ |
| 2023-12-31 | Castagna Michael | Director / Officer | A-Award | A | Common Stock, $0.01 Par Value | 209 | 3.09 | 645.81 | 2,153,509 | — | ↗ |
| 2023-12-31 | BLANK BURKHARD | Officer | A-Award | A | Common Stock, $0.01 Par Value | 5,000 | 3.09 | 15.5K | 215,000 | — | ↗ |
| 2023-12-15 | Castagna Michael | Director / Officer | S-Sale | D | Common Stock, $.01 Par Value | 90,482 | 4.00 | 361.9K | 2,148,665 | — | ↗ |
| 2023-12-14 | Castagna Michael | Director / Officer | S-Sale | D | Common Stock, $.01 Par Value | 100,000 | 4.00 | 400.0K | 2,239,147 | — | ↗ |
| 2023-11-01 | Castagna Michael | Director / Officer | S-Sale | D | Common Stock, $.01 Par Value | 10,000 | 4.25 | 42.5K | 2,349,147 | — | ↗ |
| 2023-10-31 | Singh Sanjay R | Officer | F-InKind | D | Common Stock, $.01 Par Value | 17,071 | 4.29 | 73.2K | 270,179 | — | ↗ |
| 2023-10-02 | Castagna Michael | Director / Officer | S-Sale | D | Common Stock, $.01 Par Value | 10,000 | 4.08 | 40.8K | 2,359,147 | — | ↗ |
| 2023-09-05 | Castagna Michael | Director / Officer | J-Other | D | Common Stock, $.01 Par Value | 66,892 | 4.91 | 328.4K | 2,369,147 | — | ↗ |
| 2023-09-01 | Castagna Michael | Director / Officer | S-Sale | D | Common Stock, $.01 Par Value | 10,000 | 4.61 | 46.1K | 2,436,039 | — | ↗ |
| 2023-08-28 | Thomson David | Officer | S-Sale | D | Common Stock, $.01 Par Value | 8,100 | 4.78 | 38.7K | 798,835 | — | ↗ |
| 2023-08-27 | Tross Stuart A | Officer | F-InKind | D | Common Stock, $.01 Par Value | 20,328 | 4.72 | 95.9K | 1,004,424 | — | ↗ |
| 2023-08-27 | Thomson David | Officer | F-InKind | D | Common Stock, $.01 Par Value | 20,328 | 4.72 | 95.9K | 806,935 | — | ↗ |
| 2023-08-27 | Castagna Michael | Director / Officer | F-InKind | D | Common Stock, $.01 Par Value | 50,696 | 4.72 | 239.3K | 2,446,039 | — | ↗ |
| 2023-08-27 | Binder Steven B. | Officer | F-InKind | D | Common Stock, $.01 Par Value | 20,328 | 4.72 | 95.9K | 856,134 | — | ↗ |
| 2023-08-07 | Binder Steven B. | Director | A-Award | A | Employee Stock Option (Right to Buy) | 45,025 | 1.47 | 66.2K | 45,025 | D | ↗ |
| 2023-08-01 | Castagna Michael | Director / Officer | S-Sale | D | Common Stock, $.01 Par Value | 10,000 | 4.57 | 45.7K | 2,496,735 | — | ↗ |
| 2023-07-05 | Castagna Michael | Director / Officer | S-Sale | D | Common Stock, $.01 Par Value | 5,586 | 4.01 | 22.4K | 2,506,735 | — | ↗ |
| 2023-07-03 | Castagna Michael | Director / Officer | S-Sale | D | Common Stock, $.01 Par Value | 4,414 | 4.07 | 18.0K | 2,512,321 | — | ↗ |
| 2023-06-30 | Tross Stuart A | Officer | A-Award | A | Common Stock, $0.01 Par Value | 4,012 | 3.46 | 13.9K | 1,008,436 | — | ↗ |
| 2023-06-30 | Castagna Michael | Director / Officer | A-Award | A | Common Stock, $0.01 Par Value | 4,635 | 3.46 | 16.0K | 2,153,300 | — | ↗ |
| 2023-06-01 | Castagna Michael | Director / Officer | S-Sale | D | Common Stock, $.01 Par Value | 10,000 | 4.53 | 45.3K | 2,516,735 | — | ↗ |
| 2023-05-26 | Castagna Michael | Director / Officer | S-Sale | D | Common Stock, $.01 Par Value | 75,000 | 4.50 | 337.3K | 2,526,735 | — | ↗ |
| 2023-05-25 | Tross Stuart A | Officer | A-Award | A | Performance Restricted Stock Unit | 113,000 | 0.00 | — | 113,000 | — | ↗ |
| 2023-05-25 | Thomson David | Officer | A-Award | A | Common Stock, $.01 Par Value | 92,000 | 0.00 | — | 827,263 | — | ↗ |
| 2023-05-25 | Singh Sanjay R | Officer | A-Award | A | Performance Restricted Stock Unit | 85,000 | 0.00 | — | 85,000 | — | ↗ |
| 2023-05-25 | Shannon James Samuel | Director | A-Award | A | Restricted Stock Unit | 47,393 | 0.00 | — | 47,393 | — | ↗ |
| 2023-05-25 | Sabella Lauren M | Officer | A-Award | A | Common Stock, $.01 Par Value | 23,250 | 0.00 | — | 247,434 | — | ↗ |
| 2023-05-25 | MUNDKUR CHRISTINE | Director | A-Award | A | Restricted Stock Unit | 35,545 | 0.00 | — | 35,545 | — | ↗ |
| 2023-05-25 | Kay Sabrina | Director | A-Award | A | Restricted Stock Unit | 35,545 | 0.00 | — | 35,545 | — | ↗ |
| 2023-05-25 | KRESA KENT | Director | A-Award | A | Restricted Stock Unit | 47,393 | 0.00 | — | 47,393 | — | ↗ |
| 2023-05-25 | HOOPER ANTHONY C | Director | A-Award | A | Restricted Stock Unit | 47,393 | 0.00 | — | 47,393 | — | ↗ |
| 2023-05-25 | Grancio Jennifer | Director | A-Award | A | Restricted Stock Unit | 35,545 | 0.00 | — | 35,545 | — | ↗ |
| 2023-05-25 | Friedman Michael A | Director | A-Award | A | Restricted Stock Unit | 35,545 | 0.00 | — | 35,545 | — | ↗ |
| 2023-05-25 | Castagna Michael | Director / Officer | A-Award | A | Common Stock, $.01 Par Value | 345,000 | 0.00 | — | 2,676,735 | — | ↗ |
| 2023-05-25 | CONSIGLIO RONALD J | Director | A-Award | A | Restricted Stock Unit | 35,545 | 0.00 | — | 35,545 | — | ↗ |
| 2023-05-25 | Binder Steven B. | Officer | A-Award | A | Common Stock, $.01 Par Value | 92,000 | 0.00 | — | 930,324 | — | ↗ |
| 2023-05-25 | BLANK BURKHARD | Officer | A-Award | A | Restricted Stock Unit | 210,000 | 0.00 | — | 210,000 | — | ↗ |
| 2023-05-24 | Thomson David | Officer | S-Sale | D | Common Stock, $.01 Par Value | 95,576 | 4.68 | 447.8K | 735,263 | — | ↗ |
| 2023-05-24 | Castagna Michael | Director / Officer | S-Sale | D | Common Stock, $.01 Par Value | 150,000 | 4.69 | 702.8K | 2,331,735 | — | ↗ |
| 2023-05-24 | Binder Steven B. | Officer | S-Sale | D | Common Stock, $.01 Par Value | 47,810 | 4.68 | 223.5K | 838,324 | — | ↗ |
| 2023-05-24 | BLANK BURKHARD | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-05-22 | Tross Stuart A | Officer | A-Award | A | Common Stock, $.01 Par Value | 400,000 | 4.79 | 1.92M | 1,212,750 | — | ↗ |
| 2023-05-22 | Thomson David | Officer | F-InKind | D | Common Stock, $.01 Par Value | 281,414 | 4.79 | 1.35M | 830,839 | — | ↗ |
| 2023-05-22 | Sabella Lauren M | Officer | A-Award | A | Restricted Stock Unit | 210,000 | 0.00 | — | 224,184 | — | ↗ |
| 2023-05-22 | Castagna Michael | Director / Officer | F-InKind | D | Common Stock, $.01 Par Value | 500,000 | 4.79 | 2.40M | 2,481,735 | — | ↗ |
| 2023-05-22 | Binder Steven B. | Officer | F-InKind | D | Common Stock, $.01 Par Value | 227,405 | 4.79 | 1.09M | 886,134 | — | ↗ |
| 2023-05-18 | Tross Stuart A | Officer | F-InKind | D | Common Stock, $.01 Par Value | 5,941 | 4.56 | 27.1K | 812,750 | — | ↗ |
| 2023-05-18 | Thomson David | Officer | F-InKind | D | Common Stock, $.01 Par Value | 6,001 | 4.56 | 27.4K | 712,253 | — | ↗ |
| 2023-05-18 | Castagna Michael | Director / Officer | F-InKind | D | Common Stock, $.01 Par Value | 16,434 | 4.56 | 74.9K | 1,981,735 | — | ↗ |
| 2023-05-18 | Binder Steven B. | Officer | F-InKind | D | Common Stock, $.01 Par Value | 5,972 | 4.56 | 27.2K | 713,539 | — | ↗ |
| 2023-05-15 | Tross Stuart A | Officer | A-Award | A | Common Stock,$.01 par value | 10,000 | 4.23 | 42.3K | 818,691 | — | ↗ |
Executive team
Top executives
EBIT / Employee
37.8K
Shares Outstanding
308.80M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Michael E. Castagna Chief Executive Officer | 789.4K | — | 7.69M | — | 675.8K | 145.8K | 9.30M | 82.68% | ↗ |
| 2 | 2025 | Dominic Marasco President, Endocrine Business Unit | 447.6K | — | 6.27M | — | 239.5K | 24.4K | 6.98M | 89.81% | ↗ |
| 3 | 2025 | David B. Thomson EVP, General Counsel and Secretary | 520.7K | — | 2.13M | — | 378.6K | 122.4K | 3.16M | 67.62% | ↗ |
| 4 | 2025 | Stuart A. Tross EVP, Human Resources | 438.7K | — | 2.13M | — | 234.7K | 138.8K | 2.95M | 72.43% | ↗ |
| 5 | 2025 | Christopher B. Prentiss Chief Financial Officer | 470.1K | — | 2.13M | — | 251.5K | 31.7K | 2.89M | 73.90% | ↗ |
| 6 | 2024 | Michael E. Castagna Chief Executive Officer | 766.4K | — | 7.93M | — | 766.4K | 27.8K | 9.49M | 83.56% | ↗ |
| 7 | 2024 | Christopher B. Prentiss Chief Financial Officer | 300.8K | — | 2.66M | — | 188.0K | 201.6K | 3.35M | 79.41% | ↗ |
| 8 | 2024 | David B. Thomson EVP, General Counsel and Secretary | 505.6K | — | 2.20M | — | 316.0K | 36.9K | 3.06M | 71.95% | ↗ |
| 9 | 2024 | Lauren M. Sabella EVP, Chief Operating Officer | 449.6K | — | 2.20M | — | 281.0K | 38.2K | 2.97M | 74.11% | ↗ |
| 10 | 2024 | Burkhard Blank EVP, Chief Medical Officer | 449.6K | — | 2.20M | — | 281.0K | 26.2K | 2.96M | 74.42% | ↗ |
| 11 | 2024 | Stuart A. Tross EVP, Human Resources | 425.9K | — | 2.20M | — | 266.2K | 39.1K | 2.93M | 75.07% | ↗ |
| 12 | 2024 | Steven B. Binder Former Chief Financial Officer | 396.1K | — | 1.28M | — | 247.5K | 202.0K | 2.12M | 60.16% | ↗ |
| 13 | 2023 | Michael E. Castagna Chief Executive Officer | 701.5K | — | 5.54M | — | 808.2K | 21.8K | 7.07M | 78.33% | ↗ |
| 14 | 2023 | David B. Thomson EVP, General Counsel and Secretary | 489.6K | — | 1.48M | — | 352.5K | 20.1K | 2.34M | 63.20% | ↗ |
| 15 | 2023 | Steven B. Binder Former Chief Financial Officer | 482.8K | — | 1.48M | — | 347.6K | 23.9K | 2.34M | 63.42% | ↗ |
| 16 | 2023 | Steven B. Binder Chief Financial Officer | 482.8K | — | 1.48M | — | 347.6K | 23.9K | 2.34M | 63.42% | ↗ |
| 17 | 2023 | Stuart A. Tross EVP, Chief People and Workplace Officer | 412.5K | — | 1.48M | — | 297.0K | 30.0K | 2.22M | 66.70% | ↗ |
| 18 | 2023 | Stuart A. Tross EVP, Human Resources | 412.5K | — | 1.48M | — | 297.0K | 30.0K | 2.22M | 66.70% | ↗ |
| 19 | 2023 | Lauren M. Sabella EVP, Chief Operating Officer | 321.5K | — | 1.35M | — | 231.5K | 5.7K | 1.91M | 70.69% | ↗ |
| 20 | 2023 | Burkhard Blank EVP, Chief Medical Officer | 250.5K | — | 955.5K | — | 180.3K | 5.4K | 1.39M | 68.66% | ↗ |
| 21 | 2022 | Michael E. Castagna Chief Executive Officer | 623.4K | — | 2.65M | — | 571.6K | 63.7K | 3.91M | 67.77% | ↗ |
| 22 | 2022 | Steven B. Binder Former Chief Financial Officer | 464.9K | — | 936.5K | — | 304.5K | 30.8K | 1.74M | 53.92% | ↗ |
| 23 | 2022 | Steven B. Binder Chief Financial Officer | 464.9K | — | 936.5K | — | 304.5K | 30.8K | 1.74M | 53.92% | ↗ |
| 24 | 2022 | David B. Thomson EVP, General Counsel and Secretary | 471.5K | — | 936.5K | — | 308.8K | 18.2K | 1.74M | 53.98% | ↗ |
| 25 | 2022 | Stuart Tross EVP, Chief People and Workplace Officer | 397.2K | — | 936.5K | — | 260.2K | 21.0K | 1.61M | 57.99% | ↗ |
| 26 | 2022 | Stuart A. Tross EVP, Chief People and Workplace Officer | 397.2K | — | 936.5K | — | 260.2K | 21.0K | 1.61M | 57.99% | ↗ |
| 27 | 2022 | Joseph Kocinsky Former Chief Technology Officer | 416.3K | — | 936.5K | — | 187.3K | 31.5K | 1.57M | 59.59% | ↗ |
| 28 | 2022 | Alejandro Galindo Former EVP, Endocrine Business Unit | 415.7K | — | 936.5K | — | — | 24.1K | 1.38M | 68.05% | ↗ |
| 29 | 2022 | Sanjay Singh EVP, Technical Operations | 53.8K | — | 758.2K | — | 26.9K | 14.5K | 853.5K | 88.83% | ↗ |
| 30 | 2021 | Michael E. Castagna Chief Executive Officer | 598.5K | — | 2.91M | — | 481.8K | 39.0K | 4.03M | 72.23% | ↗ |
| 31 | 2021 | David B. Thomson EVP, General Counsel and Secretary | 454.8K | — | 1.03M | — | 296.1K | 22.0K | 1.80M | 57.14% | ↗ |
| 32 | 2021 | David B. Thomson General Counsel and Secretary | 454.8K | — | 1.03M | — | 296.1K | 22.0K | 1.80M | 57.14% | ↗ |
| 33 | 2021 | Steven B. Binder Chief Financial Officer | 447.4K | — | 1.03M | — | 291.8K | 32.9K | 1.80M | 57.13% | ↗ |
| 34 | 2021 | Stuart Tross EVP, Chief People and Workplace Officer | 383.2K | — | 1.03M | — | 254.9K | 14.8K | 1.68M | 61.15% | ↗ |
| 35 | 2021 | Stuart A. Tross EVP, Chief People and Workplace Officer | 383.2K | — | 1.03M | — | 254.9K | 14.8K | 1.68M | 61.15% | ↗ |
| 36 | 2021 | Stuart Tross Chief People and Workplace Officer | 383.2K | — | 1.03M | — | 254.9K | 14.8K | 1.68M | 61.15% | ↗ |
| 37 | 2021 | Joseph Kocinsky Former Chief Technology Officer | 401.6K | — | 1.03M | — | 180.7K | 26.5K | 1.64M | 62.81% | ↗ |
| 38 | 2021 | Joseph Kocinsky Chief Technology Officer | 401.6K | — | 1.03M | — | 180.7K | 26.5K | 1.64M | 62.81% | ↗ |
| 39 | 2020 | Michael E. Castagna Chief Executive Officer | 495.2K | — | 2.58M | — | 450.6K | 37.2K | 3.56M | 72.41% | ↗ |
| 40 | 2020 | David B. Thomson General Counsel and Secretary | 429.1K | — | 1.03M | — | 278.9K | 20.7K | 1.76M | 58.63% | ↗ |
| 41 | 2020 | David B. Thomson EVP, General Counsel and Secretary | 429.1K | — | 1.03M | — | 278.9K | 20.7K | 1.76M | 58.63% | ↗ |
| 42 | 2020 | Steven B. Binder Chief Financial Officer | 396.2K | — | 1.03M | — | 257.5K | 21.1K | 1.71M | 60.49% | ↗ |
| 43 | 2020 | Joseph Kocinsky Chief Technology Officer | 378.8K | — | 1.03M | — | 246.2K | 17.9K | 1.68M | 61.63% | ↗ |
| 44 | 2020 | Joseph Kocinsky Former Chief Technology Officer | 378.8K | — | 1.03M | — | 246.2K | 17.9K | 1.68M | 61.63% | ↗ |
| 45 | 2020 | Stuart Tross EVP, Chief People and Workplace Officer | 361.5K | — | 1.03M | — | 235.0K | 41.9K | 1.67M | 61.80% | ↗ |
| 46 | 2020 | Stuart Tross Chief People and Workplace Officer | 361.5K | — | 1.03M | — | 235.0K | 41.9K | 1.31M | 78.86% | ↗ |
| 47 | 2019 | Michael E. Castagna, PharmD Chief Executive Officer | 511.0K | — | 90.0K | 617.6K | 285.1K | 48.1K | 1.55M | 45.60% | ↗ |
| 48 | 2019 | Michael E. Castagna Chief Executive Officer | 511.0K | — | 90.0K | 617.6K | 285.1K | 48.1K | 1.55M | 45.60% | ↗ |
| 49 | 2019 | David M. Kendall, M.D. Chief Medical Officer | 434.3K | 50.0K | 55.2K | 247.5K | 202.0K | 26.0K | 1.01M | 29.82% | ↗ |
| 50 | 2019 | David B. Thomson General Counsel and Secretary | 442.8K | — | 65.0K | 247.5K | 205.9K | 27.3K | 988.4K | 31.61% | ↗ |
| 51 | 2019 | David B. Thomson, Ph.D., J.D. General Counsel and Secretary | 442.8K | — | 65.0K | 247.5K | 205.9K | 27.3K | 988.4K | 31.61% | ↗ |
| 52 | 2019 | Steven B. Binder Chief Financial Officer | 408.8K | — | 60.0K | 247.5K | 190.1K | 31.6K | 937.9K | 32.78% | ↗ |
| 53 | 2019 | James P. McCauley, Jr. Chief Commercial Officer | 408.8K | — | 60.0K | 247.5K | 190.1K | 15.2K | 921.5K | 33.36% | ↗ |
| 54 | 2018 | Michael E. Castagna Chief Executive Officer | 500.0K | 20.0K | — | 833.0K | 150.0K | 5.7K | 1.51M | 55.21% | ↗ |
| 55 | 2018 | Michael E. Castagna, PharmD Chief Executive Officer | 500.0K | 20.0K | — | 833.0K | 150.0K | 5.7K | 1.51M | 55.21% | ↗ |
| 56 | 2018 | Michael E. Castagna, Pharm.D. Chief Executive Officer | 500.0K | 20.0K | — | 833.0K | 150.0K | 5.7K | 1.51M | 55.21% | ↗ |
| 57 | 2018 | David M. Kendall, M.D. Chief Medical Officer | 367.8K | 50.0K | — | 461.7K | 91.9K | 175.5K | 1.15M | 40.25% | ↗ |
| 58 | 2018 | James P. McCauley, Jr. Chief Commercial Officer | 400.0K | — | — | 333.8K | 100.0K | 231.6K | 1.07M | 31.33% | ↗ |
| 59 | 2018 | David B. Thomson, Ph.D., J.D. General Counsel and Secretary | 433.3K | 20.0K | — | 333.8K | 108.3K | 19.7K | 915.1K | 36.48% | ↗ |
| 60 | 2018 | David B. Thomson General Counsel and Secretary | 433.3K | 20.0K | — | 333.8K | 108.3K | 19.7K | 915.1K | 36.48% | ↗ |
| 61 | 2018 | Steven B. Binder Chief Financial Officer | 400.0K | — | — | 333.8K | 100.0K | 20.5K | 854.3K | 39.08% | ↗ |
| 62 | 2017 | Michael E. Castagna, PharmD Chief Executive Officer | 458.7K | — | — | 606.2K | 247.7K | 20.6K | 1.33M | 45.47% | ↗ |
| 63 | 2017 | Michael E. Castagna, Pharm.D Chief Executive Officer | 458.7K | — | — | 606.2K | 247.7K | 20.6K | 1.33M | 45.47% | ↗ |
| 64 | 2017 | Michael E. Castagna, Pharm.D. Chief Executive Officer | 458.7K | — | — | 606.2K | 247.7K | 20.6K | 1.33M | 45.47% | ↗ |
| 65 | 2017 | Stuart A. Tross Chief People and Workplace Officer | 365.0K | 35.0K | 54.0K | 410.6K | 164.3K | 13.2K | 1.04M | 44.59% | ↗ |
| 66 | 2017 | David B. Thomson, Ph.D., J.D. General Counsel and Secretary | 435.8K | — | — | 151.1K | 193.9K | 36.2K | 817.1K | 18.49% | ↗ |
| 67 | 2017 | David Thomson, Ph.D., J.D. General Counsel and Secretary | 435.8K | — | — | 151.1K | 193.9K | 36.2K | 817.1K | 18.49% | ↗ |
| 68 | 2017 | Matthew J. Pfeffer Chief Executive Officer and Chief Financial Officer (Former) | 575.4K | — | — | — | 144.0K | 27.2K | 746.7K | 0.00% | ↗ |
| 69 | 2017 | Joseph Kocinsky Chief Technology Officer | 380.5K | — | — | 151.1K | 171.2K | 5.1K | 707.9K | 21.34% | ↗ |
| 70 | 2017 | Rosabel R. Alinaya Acting Chief Financial Officer (Former) | 304.4K | — | — | 117.3K | 82.2K | 15.7K | 519.6K | 22.58% | ↗ |
| 71 | 2017 | Steven B. Binder Chief Financial Officer | 176.9K | 50.0K | — | 190.2K | 79.6K | 18.6K | 515.3K | 36.91% | ↗ |
| 72 | 2016 | Matthew J. Pfeffer Chief Executive Officer and Chief Financial Officer (Former) | 490.4K | — | — | 2.70M | 176.5K | 33.4K | 3.40M | 79.43% | ↗ |
| 73 | 2016 | Matthew J. Pfeffer Chief Executive Officer and Chief Financial Officer | 490.4K | — | — | 2.70M | — | 33.4K | 3.23M | 83.77% | ↗ |
| 74 | 2016 | Michael E. Castagna, Pharm.D Chief Executive Officer | 315.4K | — | 72.8K | 1.21M | 144.6K | 13.0K | 1.76M | 73.05% | ↗ |
| 75 | 2016 | Michael E. Castagna, Pharm.D. Chief Executive Officer | 315.4K | — | 72.8K | 1.21M | 144.6K | 13.0K | 1.76M | 73.05% | ↗ |
| 76 | 2016 | Michael E. Castagna, Pharm.D. Corporate Vice President, Chief Commercial Officer | 315.4K | — | 72.8K | 1.21M | 50.0K | 13.0K | 1.66M | 77.21% | ↗ |
| 77 | 2016 | David B. Thomson, Ph.D., J.D. General Counsel and Secretary | 424.8K | — | — | 767.8K | 127.4K | 33.9K | 1.35M | 56.71% | ↗ |
| 78 | 2016 | David Thomson, Ph.D., J.D. General Counsel and Secretary | 424.8K | — | — | 767.8K | 127.4K | 33.9K | 1.35M | 56.71% | ↗ |
| 79 | 2016 | Raymond Urbanski, M.D. Corporate Vice President, Chief Medical Officer | 400.0K | — | — | 767.8K | — | 101.3K | 1.27M | 60.50% | ↗ |
| 80 | 2016 | David Thomson, Ph.D., J.D. Corporate Vice President, General Counsel and Secretary | 424.8K | — | — | 767.8K | — | 33.9K | 1.23M | 62.60% | ↗ |
| 81 | 2016 | Alfred E. Mann Former Chairman and Chief Executive Officer | 40.6K | — | — | — | — | — | 40.6K | 0.00% | ↗ |
| 82 | 2015 | Hakan S. Edstrom Former President, Chief Executive Officer and Director | 887.6K | — | 415.7K | 1.87M | 647.0K | 27.2K | 3.85M | 59.42% | ↗ |
| 83 | 2015 | Juergen A. Martens, Ph.D. Former Chief Operating Officer | 528.1K | — | 118.8K | 505.8K | 345.0K | 25.2K | 1.52M | 41.01% | ↗ |
| 84 | 2015 | Matthew J. Pfeffer Chief Executive Officer and Chief Financial Officer (Former) | 508.8K | — | 63.0K | 282.7K | 335.5K | 31.7K | 1.22M | 28.29% | ↗ |
| 85 | 2015 | Matthew J. Pfeffer Chief Executive Officer and Chief Financial Officer | 508.8K | — | 63.0K | 282.7K | 335.5K | 31.7K | 1.22M | 28.31% | ↗ |
| 86 | 2015 | David Thomson, Ph.D., J.D. General Counsel and Secretary | 440.4K | — | 63.0K | 282.7K | 294.6K | 42.3K | 1.12M | 30.78% | ↗ |
| 87 | 2015 | David Thomson, Ph.D., J.D. Corporate Vice President, General Counsel and Secretary | 440.4K | — | 63.0K | 282.7K | 294.6K | 42.3K | 1.12M | 30.78% | ↗ |
| 88 | 2015 | Joseph Kocinsky Corporate Vice President, Chief Technology Officer | 371.4K | — | 80.9K | 262.8K | 146.6K | 2.6K | 864.4K | 39.77% | ↗ |
| 89 | 2015 | Diane Palumbo Former Corporate Vice President, Human Resources | 355.5K | — | — | — | 237.9K | 22.0K | 615.4K | 0.00% | ↗ |
| 90 | 2015 | Alfred E. Mann Former Chairman and Chief Executive Officer | 280.2K | — | — | — | — | 19.0K | 299.2K | 0.00% | ↗ |
| 91 | 2014 | Hakan S. Edstrom Former President, Chief Executive Officer and Director | 748.8K | — | 319.1K | 941.6K | 647.0K | 30.8K | 2.69M | 46.91% | ↗ |
| 92 | 2014 | Hakan S. Edstrom President, Chief Operating Officer and Director | 748.8K | — | 319.1K | 941.6K | 647.0K | 30.8K | 2.69M | 46.91% | ↗ |
| 93 | 2014 | Alfred E. Mann Former Chairman and Chief Executive Officer | 858.6K | — | 365.8K | 1.08M | — | 43.0K | 2.34M | 61.53% | ↗ |
| 94 | 2014 | Alfred E. Mann Chief Executive Officer and Chairman of the Board of Directors | 858.6K | — | 365.8K | 1.08M | — | 43.0K | 2.34M | 61.53% | ↗ |
| 95 | 2014 | Juergen A. Martens, Ph.D. Corporate Vice President, Chief Technical Officer | 479.2K | — | 81.5K | 240.9K | 345.0K | 31.4K | 1.18M | 27.37% | ↗ |
| 96 | 2014 | Juergen A. Martens, Ph.D. Former Chief Operating Officer | 479.2K | — | 81.5K | 240.9K | 345.0K | 31.4K | 1.18M | 27.37% | ↗ |
| 97 | 2014 | Matthew J. Pfeffer Corporate Vice President and Chief Financial Officer | 466.0K | — | 68.8K | 202.2K | 335.5K | 37.6K | 1.11M | 24.41% | ↗ |
| 98 | 2014 | Matthew J. Pfeffer Chief Executive Officer and Chief Financial Officer | 466.0K | — | 68.8K | 202.2K | 335.5K | 37.6K | 1.11M | 24.41% | ↗ |
| 99 | 2014 | David Thomson, Ph.D., J.D. Corporate Vice President, General Counsel and Secretary | 409.2K | — | 68.8K | 202.2K | 294.6K | 33.1K | 1.01M | 26.89% | ↗ |
| 100 | 2014 | David Thomson, Ph.D., J.D. Corporate Vice President, General Counsel and Secretary | 409.2K | — | 68.8K | 202.2K | 294.6K | 33.1K | 1.01M | 26.89% | ↗ |
| 101 | 2013 | Hakan S. Edstrom Former President, Chief Executive Officer and Director | 718.9K | — | 3.78M | 2.50M | 439.9K | 26.4K | 7.46M | 84.12% | ↗ |
| 102 | 2013 | Hakan S. Edstrom President, Chief Operating Officer and Director | 718.9K | — | 3.78M | 2.50M | 439.9K | 26.4K | 7.46M | 84.12% | ↗ |
| 103 | 2013 | Alfred E. Mann Former Chairman and Chief Executive Officer | 824.0K | — | 1.63M | 2.70M | 479.1K | 22.4K | 5.65M | 76.54% | ↗ |
| 104 | 2013 | Alfred E. Mann Chief Executive Officer and Chairman of the Board of Directors | 824.0K | — | 1.63M | 2.70M | 479.1K | 22.4K | 5.65M | 76.54% | ↗ |
| 105 | 2013 | Juergen A. Martens, Ph.D. Corporate Vice President, Chief Technical Officer | 459.1K | — | 2.22M | 2.12M | 257.6K | 23.3K | 5.07M | 85.41% | ↗ |
| 106 | 2013 | Juergen A. Martens, Ph.D. Former Chief Operating Officer | 459.1K | — | 2.22M | 2.12M | 257.6K | 23.3K | 5.07M | 85.41% | ↗ |
| 107 | 2013 | Matthew J. Pfeffer Corporate Vice President and Chief Financial Officer | 440.8K | — | 2.20M | 1.61M | 224.8K | 34.5K | 4.51M | 84.49% | ↗ |
| 108 | 2013 | Matthew J. Pfeffer Chief Executive Officer and Chief Financial Officer | 440.8K | — | 2.20M | 1.61M | 224.8K | 34.5K | 4.51M | 84.49% | ↗ |
| 109 | 2013 | David Thomson, Ph.D., J.D. Corporate Vice President, General Counsel and Secretary | 387.4K | — | 2.20M | 1.61M | 197.6K | 30.9K | 4.43M | 86.09% | ↗ |
| 110 | 2013 | David Thomson, Ph.D., J.D. Corporate Vice President, General Counsel and Secretary | 387.4K | — | 2.20M | 1.61M | 197.6K | 30.9K | 4.43M | 86.09% | ↗ |
| 111 | 2012 | Hakan S. Edstrom President, Chief Operating Officer and Director | 689.9K | — | 190.2K | 1.62M | 258.5K | 26.0K | 2.78M | 64.97% | ↗ |
| 112 | 2012 | Alfred E. Mann Chief Executive Officer and Chairman of the Board of Directors | 823.6K | — | 208.8K | 1.68M | — | 30.2K | 2.74M | 68.85% | ↗ |
| 113 | 2012 | Juergen A. Martens, Ph.D. Corporate Vice President, Chief Technical Officer | 437.8K | — | 46.4K | 546.7K | 131.2K | 23.0K | 1.19M | 50.05% | ↗ |
| 114 | 2012 | Matthew J. Pfeffer Corporate Vice President and Chief Financial Officer | 412.1K | — | 39.4K | 526.7K | 123.5K | 29.8K | 1.13M | 50.04% | ↗ |
| 115 | 2012 | David Thomson, Ph.D., J.D. Corporate Vice President, General Counsel and Secretary | 371.5K | — | 40.6K | 531.3K | 111.3K | 29.3K | 1.08M | 52.76% | ↗ |
| 116 | 2012 | Matthew J. Pfeffer Corporate Vice President And Chief Financial Officer | 412.1K | — | 39.4K | 334.7K | 123.5K | 29.8K | 939.5K | 39.83% | ↗ |
| 117 | 2012 | David Thomson, Ph.D., J.D Corporate Vice President, General Counsel and Secretary | 371.5K | — | 40.6K | 339.3K | 111.3K | 29.3K | 892.1K | 42.59% | ↗ |
| 118 | 2011 | Alfred E. Mann Chief Executive Officer and Chairman of the Board of Directors | 800.6K | — | 410.4K | 1.15M | 300.0K | 2.7K | 2.67M | 58.64% | ↗ |
| 119 | 2011 | Hakan S. Edstrom President, Chief Operating Officer and Director | 669.8K | — | 388.7K | 1.07M | 251.0K | 24.4K | 2.41M | 60.73% | ↗ |
| 120 | 2011 | Juergen A. Martens, Ph.D. Corporate Vice President, Chief Technical Officer | 414.6K | — | 124.8K | 349.5K | 124.2K | 25.5K | 1.04M | 45.67% | ↗ |
| 121 | 2011 | Matthew J. Pfeffer Corporate Vice President and Chief Financial Officer | 392.9K | — | 99.9K | 275.6K | 117.7K | 25.7K | 911.7K | 41.18% | ↗ |
| 122 | 2011 | Matthew J. Pfeffer Corporate Vice President And Chief Financial Officer | 392.9K | — | 99.9K | 275.6K | 117.7K | 25.7K | 911.7K | 41.18% | ↗ |
| 123 | 2011 | Dr. Peter C. Richardson Chief Scientific Officer | 412.1K | — | 120.1K | 237.2K | 108.0K | 14.5K | 892.0K | 40.06% | ↗ |
| 124 | 2011 | David Thomson, Ph.D., J.D. Corporate Vice President, General Counsel and Secretary | 352.1K | — | 98.7K | 272.5K | 105.5K | 23.4K | 852.1K | 43.56% | ↗ |
| 125 | 2011 | David Thomson, Ph.D., J.D Corporate Vice President, General Counsel and Secretary | 352.1K | — | 98.7K | 272.5K | 105.5K | 23.4K | 852.1K | 43.56% | ↗ |
| 126 | 2011 | David Thomson, Ph.D., J.D Corporate Vice President, General Counsel and Secretary | 352.1K | — | 98.7K | 272.5K | 105.5K | 23.4K | 852.1K | 43.56% | ↗ |
| 127 | 2010 | Alfred E. Mann Chief Executive Officer and Chairman of the Board of Directors | 773.9K | — | 273.4K | — | — | 8.1K | 1.93M | 14.15% | ↗ |
| 128 | 2010 | Alfred E. Mann Chief Executive Officer and Chairman of the Board of Directors | 773.9K | — | 273.4K | 876.6K | — | 8.1K | 1.93M | 59.53% | ↗ |
| 129 | 2010 | Hakan S. Edstrom President, Chief Operating Officer and Director | 592.2K | — | 253.2K | 856.2K | — | 24.0K | 1.73M | 64.29% | ↗ |
| 130 | 2010 | Hakan S. Edstrom President, Chief Operating Officer and Director | 592.2K | — | 253.2K | — | — | 24.0K | 1.73M | 14.67% | ↗ |
| 131 | 2010 | Juergen A. Martens, Ph.D. Corporate Vice President, Chief Technical Officer | 370.0K | — | 87.2K | — | — | 21.0K | 763.6K | 11.42% | ↗ |
| 132 | 2010 | Juergen A. Martens, Ph.D. Corporate Vice President, Chief Technical Officer | 370.0K | — | 87.2K | 285.4K | — | 21.0K | 763.6K | 48.80% | ↗ |
| 133 | 2010 | Dr. Peter C. Richardson Chief Scientific Officer | 388.9K | — | 79.5K | 265.0K | — | 14.1K | 747.4K | 46.09% | ↗ |
| 134 | 2010 | Dr. Peter C. Richardson Corporate Vice President, Chief Scientific Officer | 388.9K | — | 79.5K | — | — | 14.1K | 747.4K | 10.63% | ↗ |
| 135 | 2010 | Matthew J. Pfeffer Corporate Vice President And Chief Financial Officer | 360.0K | — | 77.1K | 252.8K | — | 28.0K | 717.8K | 45.95% | ↗ |
| 136 | 2010 | Matthew J. Pfeffer Corporate Vice President And Chief Financial Officer | 360.0K | — | 77.1K | — | — | 28.0K | 717.8K | 10.74% | ↗ |
| 137 | 2010 | David Thomson, Ph.D., J.D Corporate Vice President, General Counsel and Secretary | 318.3K | — | 77.1K | 252.8K | — | 25.2K | 673.3K | 48.99% | ↗ |
| 138 | 2009 | Alfred E. Mann Chief Executive Officer and Chairman of the Board of Directors | 750.0K | — | 299.2K | 832.8K | 506.3K | 29.5K | 2.42M | 46.82% | ↗ |
| 139 | 2009 | Alfred E. Mann Chief Executive Officer and Chairman of the Board of Directors | 750.0K | — | 299.2K | — | 506.3K | 29.5K | 2.42M | 12.38% | ↗ |
| 140 | 2009 | Hakan S. Edstrom President, Chief Operating Officer and Director | 540.0K | — | 284.2K | — | 364.5K | 22.2K | 1.99M | 14.27% | ↗ |
| 141 | 2009 | Hakan S. Edstrom President, Chief Operating Officer and Director | 540.0K | — | 284.2K | 780.7K | 364.5K | 22.2K | 1.99M | 53.47% | ↗ |
| 142 | 2009 | Dr. Peter C. Richardson Chief Scientific Officer | 378.0K | — | 109.0K | 223.8K | 204.1K | 17.1K | 932.0K | 35.70% | ↗ |
| 143 | 2009 | Dr. Peter C. Richardson Corporate Vice President, Chief Scientific Officer | 378.0K | — | 109.0K | — | 204.1K | 17.1K | 932.0K | 11.69% | ↗ |
| 144 | 2009 | Juergen A. Martens, Ph.D. Corporate Vice President, Chief Technical Officer | 360.0K | — | 109.0K | 223.8K | 170.1K | 23.6K | 886.5K | 37.54% | ↗ |
| 145 | 2009 | Juergen A. Martens, Ph.D. Corporate Vice President, Chief Technical Officer | 360.0K | — | 109.0K | — | 170.1K | 23.6K | 886.5K | 12.29% | ↗ |
| 146 | 2009 | Matthew J. Pfeffer Corporate Vice President And Chief Financial Officer | 350.0K | — | 109.0K | — | 165.4K | 21.2K | 869.3K | 12.53% | ↗ |
| 147 | 2009 | Matthew J. Pfeffer Corporate Vice President And Chief Financial Officer | 350.0K | — | 109.0K | 223.8K | 165.4K | 21.2K | 869.3K | 38.28% | ↗ |
| 148 | 2008 | Alfred E. Mann Chief Executive Officer and Chairman of the Board of Directors | 743.1K | — | 1.57M | — | 408.7K | 6.6K | 3.86M | 40.65% | ↗ |
| 149 | 2008 | Chief Executive Officer and Chairman of the Board of Directors | 743.1K | — | — | — | — | — | 3.35M | 0.00% | ↗ |
| 150 | 2008 | Hakan S. Edstrom President, Chief Operating Officer and Director | 583.3K | — | 1.35M | — | 296.0K | 24.8K | 3.12M | 43.24% | ↗ |
| 151 | 2008 | President, Chief Operating Officer and Director | 583.3K | — | — | — | — | — | 2.81M | 0.00% | ↗ |
| 152 | 2008 | Corporate Vice President, Chief Scientific Officer | 377.6K | — | — | — | — | — | 1.31M | 0.00% | ↗ |
| 153 | 2008 | Dr. Peter C. Richardson Corporate Vice President, Chief Scientific Officer | 377.6K | — | 460.9K | — | 166.1K | 15.2K | 1.28M | 35.92% | ↗ |
| 154 | 2008 | Juergen A. Martens, Ph.D. Corporate Vice President, Chief Technical Officer | 323.6K | — | 464.6K | — | 124.6K | 21.8K | 1.20M | 38.79% | ↗ |
| 155 | 2008 | Corporate Vice President, Chief Technical Officer | 323.6K | — | — | — | — | — | 1.16M | 0.00% | ↗ |
| 156 | 2008 | Matthew J. Pfeffer Corporate Vice President And Chief Financial Officer | 235.6K | — | 23.4K | — | 90.7K | 184.5K | 714.3K | 3.28% | ↗ |
| 157 | 2008 | Corporate Vice President and Chief Financial Officer | 235.6K | — | — | — | — | — | 574.2K | 0.00% | ↗ |
| 158 | 2007 | Chief Executive Officer and Chairman of the Board of Directors Richard L. Anderson | 449.2K | — | 707.0K | — | 240.3K | 5.6K | 2.27M | 31.21% | ↗ |
| 159 | 2007 | President, Chief Operating Officer and Director Dr. Peter Richardson | 449.2K | — | 412.3K | — | 240.3K | 30.6K | 2.14M | 19.31% | ↗ |
| 160 | 2007 | Corporate Vice President, General Counsel | 284.7K | — | 121.2K | — | 106.6K | 36.3K | 980.3K | 12.37% | ↗ |
| 161 | 2007 | Corporate Vice President and Chief Financial Officer Hakan S. Edstrom | 329.7K | — | 131.2K | — | 123.5K | 25.6K | 969.1K | 13.54% | ↗ |
| 162 | 2007 | Corporate Vice President, Chief Scientific Officer David Thomson | 359.4K | — | 205.1K | — | 161.2K | 13.1K | 917.9K | 22.34% | ↗ |
| 163 | 2006 | Chief Executive Officer and Chairman of the Board of Directors | 409.6K | — | — | — | — | — | 4.23M | 0.00% | ↗ |
| 164 | 2006 | President, Chief Operating Officer and Director | 409.6K | — | — | — | — | — | 3.07M | 0.00% | ↗ |
| 165 | 2006 | Chief Executive Officer and Chairman of the Board of Directors Richard L. Anderson | 409.6K | — | 746.9K | — | 184.3K | 2.2K | 2.59M | 28.82% | ↗ |
| 166 | 2006 | President, Chief Operating Officer and Director Dr. Peter Richardson | 409.6K | — | 418.7K | — | 184.3K | 25.5K | 1.94M | 21.55% | ↗ |
| 167 | 2006 | Corporate Vice President and Chief Financial Officer | 312.1K | — | — | — | — | — | 1.05M | 0.00% | ↗ |
| 168 | 2006 | Corporate Vice President, Human Resources | 221.7K | — | — | — | — | — | 892.4K | 0.00% | ↗ |
| 169 | 2006 | Corporate Vice President, General Counsel | 269.7K | — | 101.8K | — | 82.7K | 36.6K | 887.3K | 11.47% | ↗ |
| 170 | 2006 | Corporate Vice President and Chief Financial Officer Hakan S. Edstrom | 312.1K | — | 112.9K | — | 110.2K | 33.3K | 880.0K | 12.83% | ↗ |
| 171 | 2005 | Alfred E. Mann Chief Executive Officer and Chairman of the Board of Directors | 389.0K | 159.8K | — | — | — | — | 548.8K | 0.00% | ↗ |
| 172 | 2005 | Hakan S. Edstrom President, Chief Operating Officer and Director | 389.0K | 137.4K | — | — | — | 12.0K | 538.5K | 0.00% | ↗ |
| 173 | 2005 | Dan R. Burns Corporate Vice President, President Commercial Operations and Business | 305.1K | 102.2K | — | — | — | 18.8K | 426.0K | 0.00% | ↗ |
| 174 | 2005 | Richard L. Anderson Corporate Vice President and Chief Financial Officer | 300.1K | 92.9K | — | — | — | 9.0K | 402.0K | 0.00% | ↗ |
| 175 | 2005 | David Thomson Corporate Vice President, General Counsel | 250.6K | 69.3K | — | — | — | 9.0K | 328.9K | 0.00% | ↗ |
| 176 | 2004 | Hakan S. Edstrom President, Chief Operating Officer and Director | 339.0K | 132.0K | — | — | — | 12.0K | 483.0K | 0.00% | ↗ |
| 177 | 2004 | Hakan S. Edstrom President, Chief Operating Officer and Director | 339.0K | 132.0K | — | — | — | — | 471.0K | 0.00% | ↗ |
| 178 | 2004 | Dan R. Burns Corporate Vice President, President Commercial Operations and Business | 290.0K | 99.2K | — | — | — | 16.3K | 405.5K | 0.00% | ↗ |
| 179 | 2004 | Richard L. Anderson Corporate Vice President and Chief Financial Officer | 288.6K | 87.4K | — | — | — | 17.5K | 393.5K | 0.00% | ↗ |
| 180 | 2004 | Dan R. Burns Corporate Vice President, President Commercial Operations and Business | 290.0K | 99.2K | — | — | — | — | 389.2K | 0.00% | ↗ |
| 181 | 2004 | Richard L. Anderson Corporate Vice President and Chief Financial Officer | 288.6K | 87.4K | — | — | — | — | 376.0K | 0.00% | ↗ |
| 182 | 2004 | Alfred E. Mann Chief Executive Officer and Chairman of the Board of Directors | 336.4K | — | — | — | — | — | 336.4K | 0.00% | ↗ |
| 183 | 2004 | Alfred E. Mann Chief Executive Officer and Chairman of the Board of Directors | 336.4K | — | — | — | — | — | 336.4K | 0.00% | ↗ |
| 184 | 2004 | Wayman Wendell Cheatham | 257.8K | 70.0K | — | — | — | — | 327.8K | 0.00% | ↗ |
| 185 | 2004 | David Thomson Corporate Vice President, General Counsel | 239.8K | 74.1K | — | — | — | 9.0K | 323.0K | 0.00% | ↗ |
| 186 | 2003 | Hakan S. Edstrom President, Chief Operating Officer and Director | 322.1K | 87.0K | — | — | — | — | 409.1K | 0.00% | ↗ |
| 187 | 2003 | Richard L. Anderson Corporate Vice President and Chief Financial Officer | 280.3K | — | — | — | — | 60.0K | 340.2K | 0.00% | ↗ |
| 188 | 2003 | Dan R. Burns Corporate Vice President, President Commercial Operations and Business | 274.0K | — | — | — | — | 44.7K | 318.7K | 0.00% | ↗ |
| 189 | 2003 | David Thomson Corporate Vice President, General Counsel | 223.3K | 63.0K | — | — | — | — | 286.3K | 0.00% | ↗ |
| 190 | 2003 | Alfred E. Mann Chief Executive Officer and Chairman of the Board of Directors | 100.0K | — | — | — | — | — | 100.0K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Michael E. Castagna | Chief Executive Officer & Director | 2M | — |
| David Thomson | Executive Vice President, General Counsel & Secretary | 1M | — |
| Stuart A. Tross | Chief People & Workplace Officer | 812.2K | — |
| Christopher Prentiss | Chief Financial Officer | 753.3K | male |
| Dominic Marasco | President of Endocrine Business Unit | 717.7K | male |
| Sanjay Singh | Executive Vice President of Technical Operations | 364.5K | male |
| Ajay Ahuja | Executive VP & Chief Medical Officer | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MNKD
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
